Other respiratory diseases principally affecting the interstitium

J10_INTERSTITIUM

pulmonary edema: Excessive accumulation of extravascular fluid in the lung, an indication of a serious underlying disease or disorder. Pulmonary edema prevents efficient PULMONARY GAS EXCHANGE in the PULMONARY ALVEOLI, and can be life-threatening.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J80-J84 Cause of death: ICD-10 — J80-J84 2 out of 7 registries used, show all original rules.	7613
4. Check minimum number of events None	7613
5. Include endpoints J10_ARDS J10_PULMOEDEMA J10_PULMEOS J10_OTHERINSTPULM	7959
6. Filter based on genotype QC (FinnGen only)	7720

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	J10_INTERSTITIUM
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	J10_ARDS\|J10_PULMOEDEMA\|J10_PULMEOS\|J10_OTHERINSTPULM
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J8[0-4]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J8[0-4]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other respiratory diseases principally affecting the interstitium based on the number of shared cases.

Similar with more cases:

Diseases of the respiratory system

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7720	3096	4624
Unadjusted period prevalence (%)	1.71	1.10	2.12
Median age at first event (years)	69.52	66.84	71.32

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
7959: Matched controls
79586

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R03AC02

ATC

salbutamol; inhalant

2.4

315.1

4757

30156

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

310.4

3563

19980

R06.0

ICD-10 Finland

Dyspnoea

3.0

307.7

3329

15549

356

Kela drug reimbursment

Nintedanib and pirfenidone

3075.5

307.7

592

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

27.8

307.7

279

104

J18.9

ICD-10 Finland

Pneumonia, unspecified

4.1

307.7

4191

17027

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

14.9

307.7

1131

875

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

8.8

307.7

741

914

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.9

307.7

1166

3362

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

8061.9

307.7

3108

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

307.7

610

TGC00

NOMESCO Finland

Bronchial lavation

28.0

307.7

1561

687

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

16384.0

307.7

1864

J81

ICD-10 Finland

Pulmonary oedema

783.0

307.7

713

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.4

307.7

1472

5017

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

3953.9

307.7

387

H02AB06

ATC

prednisolone; systemic

4.4

307.7

5684

28776

L04AA06

ATC

mycophenolic acid; systemic

13.5

307.7

529

419

XG410

NOMESCO Finland

Flow-volume spirometry

7.5

307.7

964

1444

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.1

307.7

1619

4626

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.2

307.7

5269

30129

J96.1

ICD-10 Finland

Chronic respiratory failure

7.5

307.7

619

881

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

22.2

307.7

371

175

UGC12

NOMESCO Finland

Flexible bronchoscopy

9.1

307.7

2486

3797

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

60.5

307.7

252

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

6.6

307.7

2605

5453

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

5.6

307.7

1090

2187

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

5614.9

307.7

3478

J80

ICD-10 Finland

Adult respiratory distress syndrome

2349.1

307.7

464

L04AX01

ATC

azathioprine; systemic

7.2

307.7

800

1222

L04AX05

ATC

pirfenidone; oral

+∞

307.7

389

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.5

307.7

914

2232

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

4.7

307.7

945

2240

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

20.4

307.7

2439

1687

GD1AD

NOMESCO Finland

Thorax CT examination

6.4

307.7

1344

2440

L01EX09

ATC

nintedanib; oral

1519.9

297.5

288

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

295.5

2183

9937

J01MA14

ATC

moxifloxacin; systemic

3.3

285.6

1220

4106

Z94.2

ICD-10 Finland

Lung transplant status

66.9

276.1

151

C03CA01

ATC

furosemide; systemic

2.2

257.4

3800

23168

P01BA02

ATC

hydroxychloroquine; oral

3.5

255.9

975

3044

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

3.9

229.5

734

2032

R03BB04

ATC

tiotropium bromide; inhalant

2.7

228.1

1423

5872

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

5.5

224.0

452

867

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

4.4

221.4

584

1402

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.7

217.8

753

2197

L01XE31

ATC

[U] nintedanib

+∞

216.6

207

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

19.5

207.1

161

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

196.2

2002

10284

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

1803.4

192.3

186

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

9.6

177.8

211

226

A02BC02

ATC

pantoprazole; systemic

2.1

177.1

5730

44120

GX1K5

NOMESCO Finland

Diffusion capacity

15.2

175.2

154

103

GX1D5

NOMESCO Finland

Flow volume spirometry

35.6

174.0

109

M05BA04

ATC

alendronic acid; oral

2.7

173.1

1068

4342

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

8.8

172.7

218

253

48499

ICD-8 Finland

Acute interstitial pneumonia

+∞

164.1

157

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

162.6

1256

5674

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.4

161.8

425

1013

J47

ICD-10 Finland

Bronchiectasis

5.3

161.5

334

653

J01MA12

ATC

levofloxacin; systemic

2.1

160.5

1972

10782

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

157.1

1756

9250

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

6.9

154.0

240

356

127

Kela drug reimbursment

Transplant complication

6.9

153.1

238

352

R03AK08

ATC

formoterol and beclometasone; inhalant

3.6

145.6

496

1424

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

144.6

1722

9258

L04AX03

ATC

methotrexate; systemic

2.6

140.9

893

3660

L04AA13

ATC

[U] leflunomide

4.9

140.4

320

680

WX892

NOMESCO Finland

Monitored bed care

2.6

139.5

886

3634

R05

ICD-10 Finland

Cough

2.0

136.2

1850

10408

J43.9

ICD-10 Finland

Emphysema, unspecified

5.1

134.8

292

594

L04AD01

ATC

ciclosporin; systemic

5.8

134.6

249

439

I50.0

ICD-10 Finland

Congestive heart failure

2.4

133.7

1070

4883

J45.1

ICD-10 Finland

Nonallergic asthma

2.7

133.5

769

3001

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

133.2

2303

14044

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

132.0

1936

11171

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

129.9

2041

12044

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

+∞

129.5

124

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.9

129.2

669

2467

GDG10

NOMESCO Finland

Bilateral transplantation of lung

170.3

127.8

134

R02

ICPC

Shortness of breath/dyspnoea

2.2

126.5

1296

6543

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

216.8

124.1

128

A07EC01

ATC

sulfasalazine; oral, rectal

2.6

122.4

762

3087

XX4BW, ,

NOMESCO Finland

31.9

122.0

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.2

122.0

1272

6459

R50.9

ICD-10 Finland

Fever, unspecified

2.1

117.6

1397

7445

R03BA08

ATC

ciclesonide; inhalant

2.6

116.7

766

3181

L01BA01

ATC

methotrexate; systemic

3.5

114.7

416

1242

WX721

NOMESCO Finland

Oxygen concentrator therapy

18.0

113.0

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.7

112.8

631

2419

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

7.2

110.6

165

233

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

110.6

1347

7228

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

109.2

2352

15173

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

108.7

1757

10378

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.4

107.8

414

1281

ZX108

NOMESCO Finland

Inhalation

8.3

107.2

141

172

WW200

NOMESCO Finland

Immunization

3.9

104.6

314

824

R4110

NOMESCO Finland

Physiotherapy

1.8

103.7

2327

15148

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

4.3

103.6

275

659

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

103.3

3761

27867

J96.0

ICD-10 Finland

Acute respiratory failure

4.9

102.9

231

484

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

9.3

102.2

123

134

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

7.0

101.3

155

225

L04AD02

ATC

tacrolimus; systemic

7.8

100.1

139

181

R04.2

ICD-10 Finland

Haemoptysis

3.0

98.9

469

1643

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

97.5

2559

17336

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

55.4

96.9

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

4.3

96.9

255

607

J01FA06

ATC

roxithromycin; oral

1.7

96.4

3084

21987

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

24.5

96.1

ZX120

NOMESCO Finland

Intravenous

2.2

95.4

908

4421

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.7

95.2

225

492

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

4.0

94.8

279

722

H02AB07

ATC

prednisone; oral

2.0

93.8

1267

7016

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.4

93.5

682

2965

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

93.1

1200

6537

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

92.0

624

2623

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

91.1

1452

8483

XG466

NOMESCO Finland

Sleep oxymetry

3.2

90.6

364

1157

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

8.0

90.5

123

156

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.7

90.5

535

2104

R81

ICPC

Pneumonia

3.0

89.7

413

1422

J01AA02

ATC

doxycycline; systemic

1.7

88.7

5988

50925

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

4.0

87.4

258

669

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.3

86.0

734

3412

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

85.7

2472

17040

WX722

NOMESCO Finland

PEEP

2.7

84.9

495

1932

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

84.7

1816

11561

WX726

NOMESCO Finland

High-flow oxygen therapy

20.5

82.8

D86.0

ICD-10 Finland

Sarcoidosis of lung

5.5

82.3

161

299

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

3.2

81.6

334

1073

R99

ICPC

Respiratory disease other

4.0

80.2

231

588

C07AB07

ATC

bisoprolol; oral

1.6

77.6

4352

34798

ZXE00

NOMESCO Finland

One hour or less

1.6

77.2

2976

21870

Z3226

NOMESCO Finland

Physiotherapist

1.8

76.3

1513

9385

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

76.1

1151

6579

WX872

NOMESCO Finland

Intensive care

2.4

75.1

547

2370

R03BA02

ATC

budesonide; inhalant

1.8

74.2

1340

8082

L88

ICPC

Rheumatoid/seropositive arthritis

2.9

73.3

369

1333

GDA10

NOMESCO Finland

Biopsy of lung

14.1

73.2

L04AA01

ATC

[U] ciclosporin

4.7

72.8

168

360

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

5.7

72.0

135

241

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.5

71.9

255

749

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

71.1

1066

6067

R28

ICPC

Limited function/disability (R)

4.3

71.0

186

441

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.3

70.4

593

2734

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

70.1

1432

8936

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

20.5

69.7

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

69.6

1776

11758

F1246, ,

NOMESCO Finland

16.9

68.6

N02AX02

ATC

tramadol; systemic, rectal

1.5

67.8

3406

26301

GX2C5

NOMESCO Finland

Short-lasting oximetry

9.0

67.5

JN4AD

NOMESCO Finland

Body CT examination

1.9

67.4

950

5295

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.9

67.1

200

522

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

3.6

66.8

224

634

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

13.2

66.4

Z3231

NOMESCO Finland

Registered nurse

1.6

66.1

2216

15641

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

24.3

64.7

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.3

63.8

243

747

R05

ICPC

Cough

1.6

63.3

1704

11395

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

63.1

468

2041

Z2221

NOMESCO Finland

Medical doctor

1.6

62.5

2042

14294

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.8

62.0

194

524

J43.8

ICD-10 Finland

Other emphysema

9.0

61.9

J01CA04

ATC

amoxicillin; systemic

1.5

61.8

5812

50637

A02BC01

ATC

omeprazole; systemic

1.5

61.3

2243

16094

F2680, ,

NOMESCO Finland

14.1

61.3

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

6.4

60.8

100

157

R03BA01

ATC

beclometasone; inhalant

1.8

60.7

1116

6733

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.2

60.6

544

2571

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.3

60.5

228

696

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

60.5

1445

9364

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

60.3

728

3843

L04AA24

ATC

abatacept; parenteral

10.6

60.3

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.8

60.2

316

1166

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

6.6

59.7

147

N02AA01

ATC

morphine; systemic, rectal

3.2

59.3

237

750

R03DC03

ATC

montelukast; oral

1.8

58.8

1091

6596

D72.1

ICD-10 Finland

Eosinophilia

8.9

58.7

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.2

58.6

503

2333

L04AB01

ATC

etanercept; parenteral

4.6

58.6

138

301

J01FF01

ATC

clindamycin; systemic

1.6

58.5

2001

14119

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

57.9

815

4529

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

57.8

854

4818

TK800

NOMESCO Finland

Hemodialysis

3.2

57.4

235

755

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

12.2

57.3

XX9XE

NOMESCO Finland

Other ultrasound examination

5.8

57.0

104

181

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

17.8

56.7

M05BA07

ATC

risedronic acid; oral

2.7

56.5

313

1188

120

Kela drug reimbursment

Hypogammaglobulinaemia

18.1

55.9

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

55.9

2615

19681

R03BA05

ATC

fluticasone; inhalant

1.7

55.9

1280

8188

A07AA02

ATC

nystatin; oral

2.1

55.6

540

2630

H02AB04

ATC

methylprednisolone; systemic

1.7

54.8

1115

6907

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

54.6

642

3355

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.3

54.3

143

341

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

54.0

1002

6049

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

12.8

53.7

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.0

53.3

601

3093

I50.1

ICD-10 Finland

Left ventricular failure

2.1

52.8

564

2846

WX730

NOMESCO Finland

Conventional respirator

3.5

52.7

184

535

J92.9

ICD-10 Finland

Pleural plaque without asbestos

3.8

52.7

163

437

J12.8

ICD-10 Finland

Other viral pneumonia

4.8

52.6

120

255

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

10.4

52.6

XX2RW, ,

NOMESCO Finland

4.6

52.5

125

275

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.8

52.5

843

4873

AN1

Coronary angiography

1.7

52.3

1138

7172

XW000

NOMESCO Finland

Bone marrow biopsy

2.3

52.3

403

1786

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

51.9

593

3065

M01CB01

ATC

sodium aurothiomalate; parenteral

3.9

51.8

153

397

5AB14, ,

NOMESCO Finland

18.7

51.7

C01DA14

ATC

isosorbide mononitrate; oral

1.5

51.4

1714

11973

J84

ICD-10 Finland

Other interstitial pulmonary diseases

501.1

50.5

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

6.8

50.3

118

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

8.6

50.3

M34.1

ICD-10 Finland

CR(E)ST syndrome

8.4

50.1

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.9

49.5

243

865

J43.2

ICD-10 Finland

Centrilobular emphysema

7.5

49.5

WZC30

NOMESCO Finland

Teaching

1.6

49.5

1209

7840

B01AA03

ATC

warfarin; systemic

1.5

49.4

1978

14348

M04AA01

ATC

allopurinol; systemic

1.6

48.9

1315

8727

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

48.7

852

5047

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.6

48.5

280

1085

A03

ICPC

Fever

1.7

48.3

963

5917

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

3.5

48.2

168

488

C03DA01

ATC

spironolactone; oral

1.7

47.6

1090

6947

A02BC05

ATC

esomeprazole; systemic

1.4

46.6

2921

23031

WX882

NOMESCO Finland

High dependency care

2.6

46.5

271

1055

ZXD05

NOMESCO Finland

Urgent procedure

1.5

46.0

2258

17008

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

45.9

1078

6909

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

45.7

376

1712

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

4.4

44.9

112

256

J45.8

ICD-10 Finland

Mixed asthma

2.6

44.9

273

1085

A10AC01

ATC

insulin (human); parenteral

1.8

44.8

668

3769

L04AB04

ATC

adalimumab; parenteral

3.5

44.6

152

435

J01FA10

ATC

azithromycin; systemic

1.4

44.1

3472

28386

J15.8

ICD-10 Finland

Other bacterial pneumonia

4.5

44.0

108

244

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.3

43.9

335

1478

5183A

ICD-9 Finland

Other diseases of lung, Pulmonary eosinophilia

+∞

43.8

G47.3

ICD-10 Finland

Sleep apnoea

1.5

43.6

1565

11056

WZA10

NOMESCO Finland

Extensive medical or dental certificate

4.1

43.5

119

292

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

43.4

3111

25017

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

42.9

1865

13690

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

9.3

42.7

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.4

42.6

107

246

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

42.6

1177

7840

Z2446

NOMESCO Finland

Social worker

2.0

42.5

473

2419

Z51.5

ICD-10 Finland

Palliative care

1.8

42.4

762

4540

E0000UV, ,

ATC

1.4

41.9

2841

22592

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

41.7

1870

13797

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

3.9

41.5

123

320

Z57.2

ICD-10 Finland

Occupational exposure to dust

6.5

41.2

104

J46

ICD-10 Finland

Status asthmaticus

2.6

41.2

243

952

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

5.1

40.8

171

JN4BD

NOMESCO Finland

Extensive body CT

1.7

40.5

886

5567

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

40.3

2305

17767

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.9

40.3

123

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.2

39.8

336

1545

M05.1

ICD-10 Finland

Rheumatoid lung disease

140.7

39.7

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

3.1

39.3

167

549

A10AB05

ATC

insulin aspart; parenteral

1.8

39.2

620

3557

R06AE07

ATC

cetirizine; oral

1.4

39.0

2727

21725

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

38.9

412

2070

M34.0

ICD-10 Finland

Progressive systemic sclerosis

13.4

38.2

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.2

38.2

347

1644

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

38.1

532

2935

XPX04

NOMESCO Finland

Angioscopy

8.9

38.0

A01AB09

ATC

miconazole; local oral

1.8

38.0

658

3875

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

37.9

474

2524

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.1

37.8

375

1838

R03AK11

ATC

formoterol and fluticasone; inhalant

2.8

37.7

197

726

XJC10

NOMESCO Finland

Oesophageal pH monitoring

5.6

37.4

125

RS123, ,

NOMESCO Finland

12.9

37.4

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.6

37.2

197

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

36.9

2644

21099

GX2D5

NOMESCO Finland

Sleep oximetry

5.8

36.7

117

N03AX16

ATC

[U] pregabalin

1.5

36.5

1657

12210

SPAT1262

SPAT

Handing over of treatment supplies

1.5

36.3

1428

10234

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

2.2

36.2

303

1389

R06.2

ICD-10 Finland

Wheezing

2.2

36.1

324

1527

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

36.1

890

5752

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

36.1

1972

15023

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

35.8

652

3893

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.9

35.6

169

592

D07AC01

ATC

betamethasone; topical

1.4

35.5

2539

20227

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

4.6

35.1

186

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

34.8

333

1609

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

95.5

34.7

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.0

34.7

366

1835

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.3

34.6

128

387

L01AA01

ATC

cyclophosphamide; systemic

5.3

34.5

131

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

34.5

504

2820

J01DB01

ATC

cefalexin; oral

1.4

34.4

5907

53670

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

34.3

319

1525

J20

ICD-10 Finland

Acute bronchitis

1.7

34.3

674

4109

J67.0

ICD-10 Finland

Farmer lung

9.6

34.1

WX740

NOMESCO Finland

Nitrogen oxide therapy

12.7

34.0

H02AB09

ATC

hydrocortisone; systemic

2.7

34.0

184

691

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.6

34.0

175

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

3.3

33.9

129

397

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.8

33.8

541

3112

R03DA04

ATC

theophylline; systemic, rectal

1.8

33.8

511

2890

A02BC03

ATC

lansoprazole; oral

1.4

33.7

2133

16625

1CX01, ,

NOMESCO Finland

11.3

33.5

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

6.7

33.5

M35.1

ICD-10 Finland

Other overlap syndromes

5.7

33.4

110

51920

ICD-8 Finland

Other diseases of respiratory system, Infiltratio pulmonis eosinophilica

+∞

33.3

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

33.2

338

1673

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.0

33.0

353

1778

XG460

NOMESCO Finland

Short time oxymetry

2.8

32.9

163

584

J01FA15

ATC

telithromycin; oral

1.7

32.8

617

3715

TGD00

NOMESCO Finland

Needle biopsy of lung

5.0

32.8

141

J94.1

ICD-10 Finland

Fibrothorax

35.2

32.7

J99.1*M35.0

ICD-10 Finland

Respiratory disorders in sicca syndrome [Sjögren]

170.7

32.7

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.9

32.7

458

2528

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.5

32.7

207

840

R03AC13

ATC

formoterol; inhalant

1.9

32.6

395

2080

R03AC12

ATC

salmeterol; inhalant

1.9

32.4

396

2091

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

4.2

32.2

208

N18.8

ICD-10 Finland

Other chronic renal failure

2.3

32.1

259

1169

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.5

31.7

1006

6877

J01MA02

ATC

ciprofloxacin; systemic

1.3

31.5

3001

24850

GAA31

NOMESCO Finland

Thoracoscopy

5.9

31.1

N05CF01

ATC

zopiclone; oral

1.4

31.1

2449

19707

ZXE20

NOMESCO Finland

More than three and less than five hours

1.5

31.1

1047

7247

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

31.1

2134

16812

R4190

NOMESCO Finland

Nutritional therapy

2.3

31.0

241

1071

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

30.9

1288

9302

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.4

30.8

216

918

M33.1

ICD-10 Finland

Other dermatomyositis

12.0

30.7

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.6

30.6

887

5942

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.4

30.6

213

903

R03AC03

ATC

terbutaline; inhalant

1.5

30.5

902

6070

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

30.4

395

2129

I25.2

ICD-10 Finland

Old myocardial infarction

1.6

30.3

698

4431

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

30.2

738

4753

R03BB01

ATC

ipratropium bromide; inhalant

1.9

30.1

386

2071

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

30.1

782

5110

M35.8

ICD-10 Finland

Other specified systemic involvement of connective tissue

10.0

30.0

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

4.6

30.0

156

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

29.9

2738

22494

J93.8

ICD-10 Finland

Other pneumothorax

4.8

29.8

141

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

7.5

29.7

XG405

NOMESCO Finland

Education on PEF monitoring

3.0

29.6

131

441

2AX04, ,

NOMESCO Finland

45.2

29.6

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

29.4

438

2463

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.6

29.4

165

631

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

29.4

192

791

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.4

29.3

163

M33.9

ICD-10 Finland

Dermatopolymyositis, unspecified

11.1

29.3

J98.4

ICD-10 Finland

Other disorders of lung

7.6

29.3

M33.2

ICD-10 Finland

Polymyositis

7.0

29.2

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

29.2

2623

21475

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

5.6

29.2

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.2

29.2

246

1132

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.2

29.1

118

378

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

29.1

580

3546

1XC02, ,

NOMESCO Finland

4.2

29.0

181

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.3

28.9

211

914

J99.0

ICD-10 Finland

Rheumatoid lung disease

80.4

28.7

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

28.6

824

5508

ZXA10

NOMESCO Finland

Bilateral

1.4

28.5

1400

10408

C09AA05

ATC

ramipril; oral

1.3

28.5

2137

17025

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.9

28.4

219

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

28.4

1197

8653

1240

FHL

Bronchoscopy

3.1

28.3

121

400

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

7.7

28.0

J01FA09

ATC

clarithromycin; systemic

1.4

27.8

1859

14537

N02AA05

ATC

oxycodone; systemic

1.4

27.7

1459

10970

318

Kela drug reimbursment

Teriparatide

4.7

27.7

134

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.1

27.5

112

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.9

27.4

129

450

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.6

27.3

594

3714

J01DA01

ATC

[U] cefalexin

1.3

27.2

4298

37847

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

3.2

27.1

105

327

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.3

27.1

165

H05AA02

ATC

teriparatide; parenteral

4.8

27.1

125

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

4.8

27.1

125

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.7

26.9

143

533

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

26.8

2341

19032

J02AC03

ATC

voriconazole; systemic

7.3

26.7

5BA08, ,

NOMESCO Finland

4.4

26.5

147

B01AC04

ATC

clopidogrel; oral

1.4

26.4

1466

11115

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.3

26.3

205

913

ZYY98

NOMESCO Finland

Missed treatment contact, no notification given by patient

6.8

26.3

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.7

26.3

561

3490

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.3

26.0

205

918

UJF32

NOMESCO Finland

Coloscopy

1.3

25.9

1970

15685

A46

ICD-10 Finland

Erysipelas

1.4

25.7

1150

8390

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.0

25.6

114

386

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

21.9

25.6

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.0

25.5

282

1438

L04AA17

ATC

[U] adalimumab

6.7

25.4

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

25.4

313

1658

M31.3

ICD-10 Finland

Wegener granulomatosis

5.5

25.3

WX002

NOMESCO Finland

Sedation and analgesia

1.4

25.3

1419

10766

J05AB11

ATC

valaciclovir; oral

1.5

25.2

898

6273

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

2.9

25.2

115

395

SPAT1255

SPAT

Intravenous administration of medicine

1.7

25.1

526

3256

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

7.6

25.0

5169X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Unspecified alveolar and parietoalveolar pneumopathy

+∞

25.0

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

25.0

2637

21956

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

24.9

251

1239

R29

ICPC

Respiratory symptom/complaint other

1.7

24.7

430

2531

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

24.6

1905

15190

RK110, ,

NOMESCO Finland

3.6

24.6

228

I27.0

ICD-10 Finland

Primary pulmonary hypertension

7.2

24.6

XF622

NOMESCO Finland

Measurement of minute volume of heart

5.7

24.5

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

3.1

24.4

101

328

XA421

NOMESCO Finland

Nocturnal polygraphy

5.6

24.4

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

3.9

24.4

179

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

24.3

390

2242

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

4.3

24.3

149

SPAT1263

SPAT

Sampling

1.3

24.3

2851

24045

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

9.7

24.1

Angiography of the heart and coronary arteries

1.6

24.0

617

4013

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.3

23.9

186

828

N03AX12

ATC

[U] gabapentin; oral

1.4

23.9

1087

7948

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

23.8

427

2534

H26.3

ICD-10 Finland

Drug-induced cataract

4.3

23.8

139

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.1

23.6

212

1001

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

4.1

23.6

157

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.4

23.5

168

721

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

3.3

23.5

264

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.3

23.5

264

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

23.5

229

1116

XQ800

NOMESCO Finland

Prick test

1.8

23.3

352

1988

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

7.0

23.3

I50

ICD-10 Finland

Heart failure

1.9

23.3

303

1634

L04AC07

ATC

tocilizumab; parenteral

6.5

23.0

R01AD08

ATC

fluticasone; nasal

1.3

23.0

1627

12783

5163A

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Idiopathic fibrosing alveolitis

+∞

22.9

5185A

ICD-9 Finland

Other diseases of lung, Pulmonary insufficiency following trauma and surgery

+∞

22.9

3AC01, ,

NOMESCO Finland

3.3

22.8

264

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.2

22.8

192

884

J45

ICD-10 Finland

Asthma

1.6

22.7

598

3911

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

22.6

303

1649

3A006, ,

NOMESCO Finland

230.6

22.6

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

3.5

22.6

217

J02AC01

ATC

fluconazole; systemic

1.3

22.5

2082

16977

C08CA05

ATC

nifedipine; systemic

1.6

22.5

521

3307

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

22.2

1237

9353

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

22.2

383

2248

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.0

22.2

336

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.8

22.2

353

2026

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.0

22.0

152

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

22.0

220

1083

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

21.8

1955

15865

L04AB05

ATC

certolizumab pegol; parenteral

6.3

21.8

M10.9

ICD-10 Finland

Gout, unspecified

1.6

21.7

595

3925

R01AD09

ATC

mometasone; nasal

1.3

21.7

2590

21809

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

21.7

634

4245

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

21.6

392

2334

RK320, ,

NOMESCO Finland

3.2

21.5

269

R03AC19

ATC

olodaterol

4.5

21.4

113

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

21.4

1645

13062

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.7

21.3

379

2245

S97

ICPC

Chronic ulcer skin

1.6

21.3

486

3073

293

Kela drug reimbursment

Baricitinib

9.0

21.2

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

5.4

21.1

Z94.0

ICD-10 Finland

Kidney transplant status

3.2

20.9

258

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.6

20.9

575

3797

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

20.8

2995

25756

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

20.8

4528

40821

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

20.7

660

4499

A28

ICPC

Limited function/disability NOS

1.3

20.7

1459

11432

132

Kela drug reimbursment

Sarcoidosis

3.8

20.6

164

C10AA03

ATC

pravastatin; oral

1.5

20.6

586

3899

M05BX04

ATC

denosumab; parenteral

1.6

20.6

446

2783

C01AA05

ATC

digoxin; systemic

1.5

20.6

781

5514

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.7

20.6

372

2214

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

20.5

912

6629

3006

Kela drug reimbursment

Baricitinib

8.2

20.5

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

20.5

588

3920

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

20.4

376

2248

WX402

NOMESCO Finland

General anaesthesia

1.4

20.4

1229

9401

J94.8

ICD-10 Finland

Other specified pleural conditions

2.3

20.2

156

693

R01AD12

ATC

fluticasone furoate; nasal

1.3

20.2

1560

12378

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.4

20.2

141

600

ZXA05

NOMESCO Finland

Left side

1.3

20.2

1821

14766

L04AA37

ATC

[U] baricitinib

8.4

20.1

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

20.0

552

3646

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

20.0

269

1466

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.2

20.0

167

767

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

19.9

1417

11110

291

Kela drug reimbursment

Tofacitinib

7.3

19.9

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.1

19.9

200

987

B01AB05

ATC

enoxaparin; parenteral

1.3

19.9

2261

18879

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

19.7

2020

16643

I73.0

ICD-10 Finland

Raynaud syndrome

2.8

19.7

100

365

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.6

19.6

439

2763

M01CB03

ATC

auranofin; oral

3.5

19.5

194

B02.9

ICD-10 Finland

Zoster without complication

1.6

19.5

479

3082

ZXA00

NOMESCO Finland

Right side

1.3

19.4

1948

16002

ZX114

NOMESCO Finland

Intramuscular

2.8

19.4

340

N02BE01

ATC

paracetamol; systemic, rectal

1.3

19.3

6489

61293

J15.1

ICD-10 Finland

Pneumonia due to Pseudomonas

7.9

19.1

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

19.1

2228

18638

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

19.0

283

1593

SPAT1325

SPAT

Vaccination

1.3

19.0

2505

21262

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

5.0

19.0

RS221, ,

NOMESCO Finland

2.6

18.7

103

392

D07AC13

ATC

mometasone; topical

1.3

18.7

1848

15141

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.5

18.6

119

487

M34.8

ICD-10 Finland

Other forms of systemic sclerosis

23.7

18.6

B01AB04

ATC

dalteparin; parenteral

1.7

18.6

375

2299

R76.0

ICD-10 Finland

Raised antibody titre

5.7

18.5

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

3.1

18.5

252

6BA02, ,

NOMESCO Finland

6.2

18.4

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

18.4

1089

8296

D07AB08

ATC

desonide; topical

1.5

18.4

676

4740

XX1VW

NOMESCO Finland

Written report from radiologist

3.3

18.4

202

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

6.4

18.3

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.4

18.3

125

527

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.4

18.3

128

546

M05BA06

ATC

ibandronic acid; systemic

2.2

18.3

146

659

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

18.3

566

3834

XF402

NOMESCO Finland

ECG with work load test

1.4

18.3

792

5728

R60.0

ICD-10 Finland

Localized oedema

1.4

18.2

898

6640

WX723

NOMESCO Finland

CPAP therapy

1.9

18.2

225

1194

L01CB

ATC

Podophyllotoxin derivatives

5.9

18.2

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

2.5

18.1

111

445

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

18.1

679

4780

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

18.1

556

3761

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

5.7

18.0

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.2

18.0

215

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.4

17.9

124

526

NDG30

NOMESCO Finland

Fusion of wrist, total

4.1

17.9

117

N07BA03

ATC

varenicline; oral

1.9

17.8

223

1188

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.9

17.8

135

Z94.1

ICD-10 Finland

Heart transplant status

6.9

17.8

L95

ICPC

Osteoporosis

1.8

17.8

249

1376

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

4.8

17.7

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

3.4

17.7

187

A11CC03

ATC

alfacalcidol; systemic

2.0

17.7

185

927

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.7

17.7

294

1710

L04AB06

ATC

golimumab; parenteral

4.0

17.6

127

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

3.8

17.6

136

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.0

17.6

199

1026

E000001, ,

ATC

1.3

17.5

1209

9420

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.7

17.5

359

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.9

17.5

203

1055

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

17.5

375

2334

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.3

17.5

134

595

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.6

17.5

160

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

3.8

17.4

137

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

17.4

497

3307

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

17.4

764

5536

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

17.4

483

3196

N18.0

ICD-10 Finland

End-stage renal disease

2.6

17.3

100

390

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

1.6

17.3

401

2544

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

17.3

280

1616

P01AB01

ATC

metronidazole; oral, rectal

1.2

17.2

2381

20267

RS230, ,

NOMESCO Finland

3.9

17.2

125

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

3.4

17.2

176

I20.09

ICD-10 Finland

Unstable angina

1.5

17.1

489

3257

L04AA29

ATC

[U] tofacitinib

6.4

17.1

WW500

NOMESCO Finland

Blood transfusion

1.7

17.1

290

1697

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

17.1

2030

16980

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

17.0

2079

17443

J99.1*M33.2

ICD-10 Finland

Respiratory disorders in polymyositis

50.1

17.0

RS220, ,

NOMESCO Finland

2.7

17.0

331

R74

ICPC

Upper respiratory infection acute

1.3

16.9

1386

11057

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

2.9

16.9

260

M30.1

ICD-10 Finland

Polyarteritis with lung involvement [Churg-Strauss]

17.4

16.9

R2110

NOMESCO Finland

Giving the first information

1.6

16.9

357

2215

R04.0

ICD-10 Finland

Epistaxis

1.5

16.9

589

4088

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.5

16.9

104

419

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

16.8

195

1013

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

16.8

601

4190

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

3.6

16.8

155

R03BB07

ATC

umeclidinium bromide; inhalant

3.0

16.7

251

C08CA02

ATC

felodipine; oral

1.4

16.7

776

5677

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

16.7

1153

8981

N17.8

ICD-10 Finland

Other acute renal failure

2.4

16.7

110

457

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

16.7

839

6221

TKC20

NOMESCO Finland

Catheterisation of bladder

1.5

16.6

560

3861

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

16.3

16.5

J86.9

ICD-10 Finland

Pyothorax without fistula

2.8

16.5

280

J98.9

ICD-10 Finland

Respiratory disorder, unspecified

5.9

16.5

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

3.3

16.5

191

UGC02

NOMESCO Finland

Rigid bronchoscopy

5.6

16.5

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.7

16.4

143

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

2.2

16.4

140

650

GDA97

NOMESCO Finland

Other thoracoscopic incision, excision of lesion or repair of lung

40.1

16.3

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.1

16.3

154

744

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

2.9

16.3

255

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.7

16.3

321

1957

N19

ICD-10 Finland

Unspecified kidney failure

1.7

16.2

308

1858

C10AA05

ATC

atorvastatin; oral

1.2

16.2

3182

28071

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

3.1

16.1

214

J05AB01

ATC

aciclovir; systemic

1.3

16.1

1307

10411

J32.4

ICD-10 Finland

Chronic pansinusitis

2.5

16.1

381

R4120

NOMESCO Finland

Occupational therapy

1.6

16.1

399

2574

B07.9

ICD-10 Finland

Verruca simplex

1.9

16.0

191

1004

C10AA01

ATC

simvastatin; oral

1.2

16.0

3505

31247

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.1

15.9

140

658

A02BA03

ATC

famotidine; systemic

1.7

15.9

291

1739

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

3.6

15.8

142

A12AA04

ATC

calcium carbonate; oral

2.3

15.8

120

531

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.5

15.8

447

2969

J01GB01

ATC

tobramycin; inhalant, parenteral

14.5

15.8

V03AE01

ATC

polystyrene sulfonate; oral

2.3

15.7

116

507

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

1.9

15.7

183

953

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.6

15.7

327

A02BA02

ATC

ranitidine; systemic

1.3

15.7

1409

11370

C07AB02

ATC

metoprolol; systemic

1.3

15.6

1649

13577

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.6

15.6

345

2165

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.1

15.6

208

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.0

15.6

163

818

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

15.6

989

7605

1CX08, ,

NOMESCO Finland

3.7

15.5

130

AK3

BLTX (both lung transplants)

160.3

15.5

WVA20

NOMESCO Finland

Medicine administration

2.0

15.5

170

868

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

2.0

15.5

164

827

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

3.2

15.4

189

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.4

15.4

660

4761

C01BD01

ATC

amiodarone; systemic

1.8

15.3

233

1321

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.0

15.3

157

783

N06AX11

ATC

mirtazapine; oral

1.2

15.2

2109

17909

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

15.2

397

2592

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

4.3

15.2

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

15.2

2560

22192

L04AA11

ATC

[U] etanercept

4.7

15.1

R24

ICPC

Haemoptysis

3.0

15.1

217

AA1AD

NOMESCO Finland

CT of head and brain

1.2

15.1

2059

17446

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

3.5

15.1

142

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

15.0

464

3141

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.7

15.0

296

1805

L01BB01, ,

ATC

6.3

15.0

B03XA02

ATC

darbepoetin alfa; parenteral

2.0

15.0

162

823

XF404

NOMESCO Finland

Ambulatory ECG

1.4

14.9

631

4541

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

2.3

14.8

105

451

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

14.8

241

4017

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

14.7

247

1441

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.9

14.7

185

989

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.3

14.7

164

ZX197, ,

NOMESCO Finland

18.4

14.7

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

3.9

14.6

108

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

14.6

273

1643

J42

ICD-10 Finland

Unspecified chronic bronchitis

2.4

14.6

412

3A064, ,

NOMESCO Finland

3.8

14.5

113

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

11.9

14.5

ZX121

NOMESCO Finland

Central venous catheter

4.4

14.5

N06DX01

ATC

memantine; oral

0.6

14.5

325

5019

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

4.8

14.5

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.5

14.4

455

3096

E000002, ,

ATC

1.4

14.3

588

4206

A01AB04

ATC

amphotericin B; local oral

1.6

14.3

325

2053

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

14.3

550

3889

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

14.3

206

1151

SPAT1260

SPAT

Consultation of another employee

1.3

14.2

1148

9122

Coronary artery bypass surgery

1.8

14.2

216

1226

NDL52

NOMESCO Finland

Tenosynovectomy of hand

3.3

14.2

163

ZY010

NOMESCO Finland

Hospital outpatient

1.8

14.1

222

1272

Z94.3

ICD-10 Finland

Heart and lungs transplant status

42.5

14.1

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

14.1

228

1318

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

3.1

14.1

179

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

11.9

14.0

A06AD11

ATC

lactulose; oral

1.3

13.9

1193

9553

207

Kela drug reimbursment

Chronic arrhythmias

1.3

13.9

1331

10808

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

4.1

13.9

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.0

13.9

154

790

I47.2

ICD-10 Finland

Ventricular tachycardia

1.9

13.9

163

853

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.2

13.8

116

536

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.5

13.8

400

2671

D07XC01

ATC

betamethasone; topical

1.4

13.8

787

5949

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.8

13.8

189

1040

J01XB01

ATC

colistin; inhalant, parenteral

23.8

13.8

N06DA03

ATC

rivastigmine; oral, transdermal

0.5

13.8

131

2552

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

13.7

722

5391

196

Kela drug reimbursment

Paricalcitol and cinacalcet

3.8

13.6

109

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

13.6

2340

20268

WX720

NOMESCO Finland

Own respiration

1.6

13.6

293

1827

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.6

13.6

281

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.7

13.6

269

1642

R03DC01

ATC

zafirlukast; oral

2.2

13.6

112

514

E84.9

ICD-10 Finland

Cystic fibrosis, unspecified

75.3

13.6

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

13.5

1718

14421

E84.0

ICD-10 Finland

Cystic fibrosis with pulmonary manifestations

34.1

13.5

WNF00

NOMESCO Finland

Infection source and contact determination

3.7

13.5

110

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

3.0

13.5

189

TFP20

NOMESCO Finland

Cardiodefibrillation

1.4

13.4

568

4085

M25.5

ICD-10 Finland

Pain in joint

1.2

13.4

1748

14709

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.8

13.4

183

1006

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

13.3

430

2939

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

13.3

126

2456

R01AD58

ATC

fluticasone, combinations; nasal

1.3

13.2

1070

8503

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

13.2

1576

13131

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

13.2

320

2055

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

9.7

13.2

NG1DA

NOMESCO Finland

X-ray of knees

2.1

13.2

118

560

WX213

NOMESCO Finland

Lower leg blockade

2.8

13.2

235

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

4.2

13.1

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

3.3

13.1

141

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

13.1

457

3172

GBB00

NOMESCO Finland

Tracheostomy

2.4

13.1

389

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

13.0

1336

10936

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

13.0

2124

18294

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

13.0

200

1141

N06DA02

ATC

donepezil; oral

0.6

12.8

229

3731

A15.0

ICD-10 Finland

Tuberculosis of lung, confirmed by sputum microscopy with or without culture

4.7

12.8

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

12.8

233

1393

XX7LW, ,

NOMESCO Finland

5.3

12.7

B01AF02

ATC

apixaban; oral

1.3

12.7

999

7902

4040, ,

NOMESCO Finland

14.0

12.7

TK810

NOMESCO Finland

Hemofiltration

3.0

12.7

185

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.2

12.7

100

451

A07AA09

ATC

vancomycin; oral

2.2

12.7

104

477

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

12.7

2740

24224

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.6

12.6

286

A12BA01

ATC

potassium chloride; oral

1.5

12.6

367

2454

A04

ICPC

Weakness/tiredness general

1.3

12.6

939

7376

ZYC01

NOMESCO Finland

Remote contact by phone

1.6

12.6

310

1998

NDG74

NOMESCO Finland

Fusion of first IP joint

4.6

12.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

12.6

657

4898

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

32.1

12.6

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.4

12.5

335

WPB10

NOMESCO Finland

Making a convalescent care decision

3.7

12.5

102

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

3.9

12.5

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

1.8

12.5

179

999

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.3

12.5

429

R53

ICD-10 Finland

Malaise and fatigue

1.2

12.4

1534

12817

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

2.8

12.4

209

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.1

12.4

110

520

S22.3

ICD-10 Finland

Fracture of rib

1.4

12.4

465

3271

B01AC06

ATC

acetylsalicylic acid; oral

1.6

12.4

312

2021

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

12.4

578

4230

ZX100

NOMESCO Finland

Oral

2.1

12.3

107

502

M06

ICD-10 Finland

Other rheumatoid arthritis

3.1

12.3

162

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.3

12.3

394

WPA13

NOMESCO Finland

Palliative consultation

3.9

12.2

WX727

NOMESCO Finland

Estimation of exercise oxygen therapy

37.6

12.2

J01FA01

ATC

erythromycin; systemic

1.4

12.2

646

4827

WPA11

NOMESCO Finland

Developing a plan for palliative care

4.9

12.1

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

12.1

156

843

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.0

12.0

180

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

1.7

12.0

215

1279

J99.1*M34.8

ICD-10 Finland

Respiratory disorders in systemic: sclerosis

26.7

12.0

R05CB01

ATC

acetylcysteine; inhalant, oral

2.0

12.0

124

621

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

12.0

1731

14698

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

5.2

12.0

WX704

NOMESCO Finland

Intubation

1.4

11.9

467

3313

C02KX04

ATC

macitentan; oral

13.4

11.9

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.1

11.9

109

523

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.9

11.8

145

771

H03AA01

ATC

levothyroxine sodium; systemic

1.3

11.8

1348

11160

NH1CM

NOMESCO Finland

Ankle and foot extensive MRI examination with 3 Tesla magnet

5.8

11.8

L03AA02

ATC

filgrastim; parenteral

1.8

11.8

183

1047

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

2.2

11.7

408

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.5

11.7

310

2031

K77

ICPC

Heart failure

1.7

11.7

189

1093

L28

ICPC

Limited function/disability (L)

1.3

11.7

1315

10865

A10AE04

ATC

insulin glargine; parenteral

1.4

11.7

649

4883

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.6

11.7

245

1520

TQW11

NOMESCO Finland

Vacuum treatment of wound

1.9

11.7

133

690

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

2.9

11.7

178

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

2.7

11.6

228

XG420

NOMESCO Finland

Time-volume spirometry

5.5

11.6

T90

ICPC

Diabetes non-insulin dependent

1.2

11.6

1715

14593

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.0

11.6

127

650

J99.1*M32.1

ICD-10 Finland

Respiratory disorders in systemic: lupus erythematosus

65.0

11.6

R03BB06

ATC

glycopyrronium bromide; inhalant

3.3

11.6

132

R07.3

ICD-10 Finland

Other chest pain

1.4

11.6

630

4726

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

11.6

541

3960

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

5.2

11.5

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

2.6

11.5

241

NHQ40

NOMESCO Finland

Amputation of toe

1.9

11.5

135

708

R04

ICPC

Breathing problem other

1.7

11.5

221

1342

XG422

NOMESCO Finland

Time-volume spirometry with bronchodialtation

5.7

11.5

51701

ICD-8 Finland

Other chronic interstitial pneumonia, Fibrosis interstitialis diffusa pulmonum essentialis (Hamman-Rich)

+∞

11.5

5168X

ICD-9 Finland

Other alveolar and parietoalveolar pneumopathy, Other specified alveolar and parietoalveolar pneumopathies

+∞

11.5

2770A

ICD-9 Finland

Other and unspecified disorders of metabolism, Cystic fibrosis

120.2

11.4

D68.8

ICD-10 Finland

Other specified coagulation defects

2.6

11.4

236

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.8

11.4

179

1028

137

Kela drug reimbursment

Uraemia requiring dialysis

2.6

11.3

237

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

2.1

11.3

102

486

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

11.3

440

3117

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.5

11.3

365

2496

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

2.7

11.3

226

TNG10

NOMESCO Finland

Puncture of knee

2.4

11.3

309

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

11.2

467

3349

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.3

11.2

334

DPA30

NOMESCO Finland

Sphenotomy

3.2

11.2

130

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.0

11.2

118

597

D07AD01

ATC

clobetasol; topical

1.3

11.1

960

7682

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

11.1

538

3960

XQ848

NOMESCO Finland

Dermatological photography

1.7

11.1

191

1125

WX204

NOMESCO Finland

Axillary plexus blockaced

1.7

11.1

186

1088

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.0

11.1

116

585

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.2

11.0

131

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.5

11.0

112

2132

B59

ICD-10 Finland

Pneumocystosis

8.5

11.0

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

1.9

11.0

145

790

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.1

11.0

472

RD210, ,

NOMESCO Finland

2.1

11.0

446

A07EC02

ATC

mesalazine; oral, rectal

1.6

11.0

280

1821

N05CD07

ATC

temazepam; oral

1.3

11.0

876

6942

SBA10

NOMESCO Finland

Measurement of salivary flow rate

2.5

10.9

259

J01DA08

ATC

[U] cefaclor

1.4

10.9

441

3146

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

2.4

10.9

289

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

3.0

10.9

158

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.1

10.9

454

NDB78

NOMESCO Finland

Prosthetic replacement of several of finger or metacarpal

5.4

10.9

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

10.8

1011

8172

J98.2

ICD-10 Finland

Interstitial emphysema

8.8

10.7

R06AX27

ATC

desloratadine; oral

1.2

10.7

1323

11036

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.7

10.7

176

1024

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

10.7

2815

25217

NDG76

NOMESCO Finland

Fusion of DIP joint

2.7

10.7

204

D11

ICPC

Diarrhoea

1.4

10.7

544

4040

EB1WA, ,

NOMESCO Finland

3.0

10.6

155

R05CB13

ATC

dornase alfa (desoxyribonuclease); inhalant

60.1

10.6

304

Kela drug reimbursment

Dornase alfa

60.1

10.6

SPAT1060

SPAT

Administration of oxygen

3.0

10.6

150

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.7

10.6

172

998

D02AE01

ATC

carbamide; topical

1.5

10.6

365

2529

F2682, ,

NOMESCO Finland

5.3

10.6

SPAT1097

SPAT

Recording of ECG

1.3

10.6

1019

8265

RS224, ,

NOMESCO Finland

3.5

10.6

100

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.1

10.6

473

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.4

10.5

413

2931

D80.8

ICD-10 Finland

Other immunodeficiencies with predominantly antibody defects

11.2

10.5

B37.0

ICD-10 Finland

Candidal stomatitis

2.4

10.5

276

J01XX08

ATC

linezolid; systemic

2.8

10.4

184

RK250, ,

NOMESCO Finland

3.1

10.4

141

E66.8

ICD-10 Finland

Other obesity

1.6

10.4

222

1385

B01AB10

ATC

tinzaparin; parenteral

1.3

10.4

598

4525

M79.6

ICD-10 Finland

Pain in limb

1.2

10.4

2512

22330

UJD02

NOMESCO Finland

Gastroscopy

1.5

10.4

315

2128

A40.0

ICD-10 Finland

Sepsis due to streptococcus, group A

3.9

10.3

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

3.2

10.2

127

J98.6

ICD-10 Finland

Disorders of diaphragm

3.2

10.2

127

FXE00

NOMESCO Finland

Use of ECLA

18.8

10.2

R11

ICD-10 Finland

Nausea and vomiting

1.4

10.2

496

3652

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

4.9

10.2

AP3

Catheterization of the right and left side of the heart

3.6

10.2

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.7

10.2

163

943

J01DA06

ATC

[U] cefuroxime

1.3

10.1

811

6425

T86.8

ICD-10 Finland

Failure and rejection of other transplanted organs and tissues

13.1

10.1

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

2.9

10.1

165

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

10.1

607

4621

C08CA01

ATC

amlodipine; oral

1.2

10.1

2901

26138

UDM02

NOMESCO Finland

Sinoscopy

1.9

10.0

119

627

51709

ICD-8 Finland

Other chronic interstitial pneumonia, Unspecified

8.4

10.0

N06AA09

ATC

amitriptyline; systemic

1.3

10.0

593

4506

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.4

10.0

530

3959

A10AB01

ATC

insulin (human); parenteral

1.7

10.0

184

1107

OAB50, ,

SPAT

1.5

9.9

336

2320

J98.1

ICD-10 Finland

Pulmonary collapse

2.6

9.9

212

M54.5

ICD-10 Finland

Low back pain

1.2

9.9

2014

17619

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.1

9.9

398

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.6

9.9

233

1488

RK120, ,

NOMESCO Finland

3.8

9.9

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.3

9.9

334

B34.9

ICD-10 Finland

Viral infection, unspecified

1.9

9.9

128

694

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

9.9

721

5645

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

3.1

9.8

125

G53.0

ICD-10 Finland

Postzoster neuralgia

2.6

9.8

219

N08.5*M31.3

ICD-10 Finland

Glomerular disorders in Wegener's granulomatosis

5.1

9.8

SPAT1254

SPAT

Administration of medicine

1.3

9.8

1015

8297

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.7

9.8

169

998

M05BA01

ATC

etidronic acid; systemic

2.8

9.8

163

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.5

9.8

296

2000

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

4.0

9.7

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.2

9.7

343

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

2.7

9.7

197

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

3.4

9.7

D05AX52

ATC

calcipotriol, combinations; topical

1.5

9.7

299

2027

R4130

NOMESCO Finland

Speech therapy

1.7

9.7

159

926

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

3.4

9.7

101

5CM18, ,

NOMESCO Finland

3.3

9.7

111

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.8

9.7

134

743

J93.9

ICD-10 Finland

Pneumothorax, unspecified

2.8

9.7

164

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

13.4

9.6

NCB20

NOMESCO Finland

Primary total prosthetic replacement of elbow joint

5.3

9.6

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

9.6

4180

38831

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

1.8

9.6

133

737

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.0

9.6

457

Z71.8

ICD-10 Finland

Other specified counselling

1.2

9.6

1678

14479

R03AC18

ATC

indacaterol; inhalant

2.4

9.6

270

M01AH02

ATC

rofecoxib; oral

1.3

9.5

847

6798

AN2

Balloon angioplasty, including several vessels

1.6

9.5

210

1322

E000003, ,

ATC

1.6

9.5

237

1535

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

2.7

9.5

188

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

15.0

9.5

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

9.1

9.5

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

1.8

9.5

142

806

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

1.8

9.5

148

851

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.7

9.4

150

866

ZY000

NOMESCO Finland

Hospital inpatient

2.6

9.4

212

SBA00

NOMESCO Finland

Microbiological examinations

1.8

9.4

142

808

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.6

9.4

193

1194

R06AE09

ATC

levocetirizine; oral

1.3

9.4

652

5069

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.5

9.4

302

2066

XX9XW, ,

NOMESCO Finland

2.8

9.3

156

A01AB10

ATC

natamycin; local oral

1.7

9.3

166

989

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

21.7

9.3

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

9.3

970

7934

Z31.5

ICD-10 Finland

Genetic counselling

1.6

9.3

193

1197

SPAT1059

SPAT

Spirometry at the office

1.5

9.3

314

2169

3005

Kela drug reimbursment

Tofacitinib

4.7

9.3

UJF92

NOMESCO Finland

Capsular endoscopy

1.9

9.3

116

623

S18

ICPC

Laceration/cut

1.2

9.3

3104

28249

49300

ICD-8 Finland

Asthma, bronchiale

1.7

9.2

149

864

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

2.5

9.2

214

V03AE02

ATC

sevelamer; oral

3.0

9.2

130

742, ,

NOMESCO Finland

3.8

9.2

RT271, ,

NOMESCO Finland

7.3

9.2

N05BA04

ATC

oxazepam; oral

1.2

9.2

1582

13624

WX780

NOMESCO Finland

Remote monitoring CPAP

1.6

9.2

208

1318

M10

ICD-10 Finland

Gout

1.5

9.2

317

2199

R96

ICPC

Asthma

1.3

9.2

544

4136

4130B

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),AHTAUTUNUT]

1.8

9.1

142

815

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.4

9.1

380

2730

SAA04

NOMESCO Finland

Special examination of mouth

1.5

9.0

256

1706

NDF10

NOMESCO Finland

Synovectomy of wrist

4.6

9.0

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.4

9.0

416

3040

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

3.0

9.0

132

AA1

Conventional CABG

1.7

9.0

164

984

XG467

NOMESCO Finland

Nocturnal CO2 monitoring

7.0

9.0

J01DA09

ATC

[U] cefadroxil

1.2

9.0

1517

13039

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

2.7

9.0

171

J37.0

ICD-10 Finland

Chronic laryngitis

1.6

8.9

181

1116

D83.0

ICD-10 Finland

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

18.6

8.9

D89.89

ICD-10 Finland

Other specified disorders involving the immune mechanism, not elsewhere classified

24.0

8.9

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.0

8.9

498

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

8.9

2445

21904

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

8.9

731

5814

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

2.2

8.9

331

ZX140

NOMESCO Finland

Intra articular

2.5

8.8

207

XX4AW, ,

NOMESCO Finland

7.9

8.8

WPA45

NOMESCO Finland

Continuous drug infusion in palliative care

4.7

8.8

AN4

Balloon angioplasty and drug eluding stent

1.5

8.8

248

1652

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

3.1

8.8

118

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

1.4

8.8

438

3242

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.6

8.7

220

1430

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

1.6

8.7

222

1446

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.4

8.7

343

2439

R52.0

ICD-10 Finland

Acute pain

1.7

8.7

162

978

M48.0

ICD-10 Finland

Spinal stenosis

1.3

8.7

877

7145

L17

ICPC

Foot/toe symptom/complaint

1.2

8.7

1765

15415

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.5

8.7

245

1632

D07AA02

ATC

hydrocortisone; topical

1.3

8.7

736

5874

4038, ,

NOMESCO Finland

50.0

8.7

E84.1

ICD-10 Finland

Cystic fibrosis with intestinal manifestations

50.0

8.7

RJ420, ,

NOMESCO Finland

3.0

8.7

119

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.7

8.7

151

896

A07EA06

ATC

budesonide; oral, local oral

1.6

8.6

177

1095

QC6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in hand

6.6

8.6

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

3.5

8.6

R06AX22

ATC

ebastine; oral

1.3

8.6

803

6483

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.0

8.6

442

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

8.6

120

668

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

4.6

8.6

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

1.6

8.6

169

1036

D83.9

ICD-10 Finland

Common variable immunodeficiency, unspecified

16.3

8.5

A11

ICPC

Chest pain NOS

1.3

8.5

516

3935

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

8.5

1094

9150

GD1CQ

NOMESCO Finland

Lung circulation SPECT with low dose CT

6.9

8.5

M32

ICD-10 Finland

Systemic lupus erythematosus

9.0

8.5

R63.4

ICD-10 Finland

Abnormal weight loss

1.5

8.5

249

1672

TGA30

NOMESCO Finland

Thoracocentesis

2.3

8.5

279

WW300

NOMESCO Finland

Transfer of autologic stem cells

3.4

8.5

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

20.0

8.5

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

2.2

8.5

305

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

3.3

8.5

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

1.8

8.4

116

643

DHA10

NOMESCO Finland

Biopsy of cavity of nose

2.5

8.4

212

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

3.7

8.4

E84.8

ICD-10 Finland

Cystic fibrosis with other manifestations

90.2

8.4

E66.01

ICD-10 Finland

Obesity due to excess calories

1.4

8.4

353

2540

M54

ICD-10 Finland

Dorsalgia

1.3

8.4

580

4509

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.5

8.4

242

1622

M01CC01

ATC

penicillamine; oral

4.5

8.3

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

2.5

8.3

207

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

8.3

2161

19246

1243

FHL

Bronchoscopy and other therapeutic procedure

6.7

8.3

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

1.7

8.3

134

778

R95

ICPC

Chron obstructive pulmonary disease

1.6

8.3

207

1342

R03BB05

ATC

aclidinium bromide; inhalant

3.2

8.3

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

2.3

8.3

244

A04AA01

ATC

ondansetron; systemic, rectal

1.4

8.3

442

3306

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

1.7

8.3

140

824

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

3.0

8.3

117

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

1.9

8.3

518

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.2

8.3

1089

9131

L95.8

ICD-10 Finland

Other vasculitis limited to skin

3.6

8.3

D05BB02

ATC

acitretin; oral

1.7

8.3

132

765

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

8.3

502

3831

I26

ICD-10 Finland

Pulmonary embolism

2.3

8.2

270

C08DB01

ATC

diltiazem; oral

1.4

8.2

415

3078

D70.89

ICD-10 Finland

Neutropenic splenomegaly

2.1

8.2

361

-1, ,

NOMESCO Finland

1.2

8.2

1685

14719

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.8

8.2

112

619

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.3

8.2

544

4204

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

3.7

8.2

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

2.0

8.1

403

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.4

8.1

234

PD3YT

NOMESCO Finland

Pelvic artery PTA with stent

2.0

8.1

417

I42.0

ICD-10 Finland

Dilated cardiomyopathy

1.6

8.1

183

1162

OAB43, ,

SPAT

0.7

8.1

430

5677

C02KX01

ATC

bosentan; oral

11.7

8.1

UDC00

NOMESCO Finland

Ear microscopy

1.4

8.1

441

3314

Z01.9

ICD-10 Finland

Special examination, unspecified

1.4

8.1

337

2424

Z94.4

ICD-10 Finland

Liver transplant status

3.8

8.0

D80.0

ICD-10 Finland

Hereditary hypogammaglobulinaemia

10.0

8.0

A05AA02

ATC

ursodeoxycholic acid; oral

2.1

8.0

365

250, ,

Kela drug reimbursment

1.9

8.0

510

K51.5

ICD-10 Finland

Left sided colitis

1.8

8.0

124

713

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.4

8.0

370

2708

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.5

8.0

182

R49.01

ICD-10 Finland

Functional dysphonia

1.6

8.0

156

956

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

3.0

7.9

115

602

Kela drug reimbursment

Children's severe malnutrition

13.0

7.9

TND10

NOMESCO Finland

Joint puncture, wrist or finger joint

3.9

7.9

H26.02

ICD-10 Finland

Presenil cataract

1.7

7.9

139

829

M10.0

ICD-10 Finland

Idiopathic gout

1.5

7.9

248

1693

R01AD05

ATC

budesonide; nasal

1.4

7.8

383

2827

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.2

7.8

1070

9001

SPAT1310

SPAT

Counselling related to known health issue

1.2

7.8

1949

17291

Z50.1

ICD-10 Finland

Other physical therapy

1.4

7.8

317

2269

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.2

7.8

264

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.6

7.8

157

969

J62.0

ICD-10 Finland

Pneumoconiosis due to talc dust

10.8

7.8

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.2

7.8

277

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

2.8

7.8

138

RJ411, ,

NOMESCO Finland

2.7

7.8

155

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.2

7.8

290

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.3

7.8

258

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

6.9

7.8

S22.2

ICD-10 Finland

Fracture of sternum

2.6

7.7

167

JN4CD

NOMESCO Finland

Very extensive body CT

1.5

7.7

242

1650

J67.8

ICD-10 Finland

Hypersensitivity pneumonitis due to other organic dusts

15.0

7.7

PE1YT

NOMESCO Finland

Femoral or popliteal artery PTA with stent

2.0

7.7

364

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.0

7.7

398

8041/3-C34.3

ICD-O-3

Small cell carcinoma, NOS, of lower lobe, lung

7.4

7.7

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.7

7.6

141

851

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.4

7.6

293

2076

A10AE05

ATC

insulin detemir; parenteral

1.4

7.6

320

2303

SPAT1211

SPAT

Application of soft bandage

1.3

7.6

530

4122

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

7.6

246

1687

ZXX05

NOMESCO Finland

Extent of procedure, 5 units

3.7

7.6

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

4.0

7.6

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

1.5

7.6

203

1339

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

2.6

7.6

157

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

7.6

887

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

1.8

7.6

109

614

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

7.6

2395

21624

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

3.6

7.6

RJ511, ,

NOMESCO Finland

4.1

7.5

WW409

NOMESCO Finland

Other aferesis

4.1

7.5

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

1.6

7.5

146

893

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

2.9

7.5

113

7102A

ICD-9 Finland

Diffuse diseases of connective tissue, Sicca syndrome[SYNDROMA SICCUM PRIMARIUM]

10.0

7.5

K29.7

ICD-10 Finland

Gastritis, unspecified

1.5

7.5

214

1431

U08.9

ICD-10 Finland

Personal history of COVID-19, unspecified

3.4

7.5

A02BA04

ATC

nizatidine; systemic

1.3

7.5

507

3929

49099

ICD-8 Finland

Bronchitis, unspecified

2.1

7.5

301

V03AE03

ATC

lanthanum carbonate; oral

3.3

7.5

PE1AT

NOMESCO Finland

Femoral artery PTA

1.9

7.5

500

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.5

7.5

202

1336

M87.0

ICD-10 Finland

Idiopathic aseptic necrosis of bone

2.5

7.5

182

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

1.8

7.5

107

602

M02AA07

ATC

piroxicam; topical

1.2

7.4

2393

21623

C61

ICD-10 Finland

Malignant neoplasm of prostate

0.8

7.4

552

6970

N07BB01

ATC

disulfiram; oral

1.6

7.4

178

1146

N06AX16

ATC

venlafaxine; oral

1.3

7.4

609

4841

GDA21

NOMESCO Finland

Thoracoscopic excision of lesion of lung

4.4

7.4

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.6

7.4

172

1100

GD1LA

NOMESCO Finland

1.8

7.4

101

560

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

7.4

886

7355

F03

ICD-10 Finland

Unspecified dementia

0.6

7.4

169

2590

ZXE70

NOMESCO Finland

Moren than 15 and less than 18 hours

3.7

7.3

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

1.7

7.3

119

694

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.2

7.3

1073

9088

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.5

7.3

247

1710

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

8.3

7.3

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.1

7.3

2488

22568

K02.1

ICD-10 Finland

Caries of dentine

1.1

7.3

3233

29851

UGC08

NOMESCO Finland

Rigid bronchoscopy with biopsy of lung

+∞

7.3

6BB16, ,

NOMESCO Finland

+∞

7.3

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

1.9

7.3

434

K08.3

ICD-10 Finland

Retained dental root

1.3

7.3

455

3488

J43.1

ICD-10 Finland

Panlobular emphysema

6.8

7.3

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

2.6

7.3

149

R05FA02

ATC

opium derivatives and expectorants; systemic

1.1

7.3

2439

22099

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

2.9

7.3

110

N02BF02

ATC

pregabalin; oral

1.4

7.2

291

2080

S29

ICPC

Skin symptom/complaint other

1.2

7.2

1147

9786

C07AA07

ATC

sotalol; systemic

1.4

7.2

290

2072

212

Kela drug reimbursment

Gout

1.6

7.2

157

988

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

3.2

7.2

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

2.7

7.2

138

B05DB

ATC

Hypertonic solutions

2.5

7.2

179

J99.1*M33.9

ICD-10 Finland

Respiratory disorders in dermatopolymyositis

30.0

7.1

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.3

7.1

223

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.2

7.1

242

H05BX01

ATC

cinacalcet; oral

2.5

7.1

174

SPAT1301

SPAT

No procedures

1.2

7.1

2084

18692

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

7.1

290

2079

J01CF05

ATC

flucloxacillin; systemic

1.4

7.1

318

2316

XX9TE

NOMESCO Finland

Compementary ultrasound examination

2.6

7.1

145

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

1.8

7.1

517

JN6AD

NOMESCO Finland

CT of torso and neck

1.8

7.1

517

A10BA02

ATC

metformin; oral

1.2

7.1

2039

18268

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

1.6

7.1

150

939

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

4.0

7.1

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

7.1

1299

11230

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

6.0

7.1

K07

ICPC

Swollen ankles/oedema

1.4

7.1

312

2268

R13

ICD-10 Finland

Dysphagia

1.3

7.0

432

3304

J62.8

ICD-10 Finland

Pneumoconiosis due to other dust containing silica

8.8

7.0

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

7.0

1474

12884

XJC00

NOMESCO Finland

Oesophageal manometry

3.0

7.0

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

1.8

7.0

533

RT272, ,

NOMESCO Finland

3.6

7.0

T92

ICPC

Gout

1.6

7.0

142

879

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

4.2

7.0

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.8

7.0

926

10972

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.0

7.0

330

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.2

7.0

821

6801

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.5

7.0

229

1577

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.7

7.0

132

803

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

2.5

7.0

164

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

1.8

7.0

102

578

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

2.3

7.0

213

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

3.4

7.0

L03

ICPC

Low back symptom/complaint

1.2

6.9

1491

13056

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.5

6.9

232

1605

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.5

6.9

174

1134

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

2.6

6.9

153

I20.0

ICD-10 Finland

Unstable angina

2.0

6.9

345

M05BB04

ATC

risedronic acid, calcium and colecalciferol, sequential; oral

3.7

6.9

RK310, ,

NOMESCO Finland

5.4

6.9

M05.0

ICD-10 Finland

Felty syndrome

5.8

6.9

5823

FHL

Lung avobiopsy and wedge resection

5.8

6.9

M31.7

ICD-10 Finland

Microscopic polyangiitis

5.8

6.9

GD1DG

NOMESCO Finland

Extremely extensive MRI examination of pleura with high field magnet

13.8

6.9

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

4.0

6.9

Z49.2

ICD-10 Finland

Other dialysis

2.3

6.9

202

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

2.7

6.8

125

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

2.4

6.8

190

B37.03

ICD-10 Finland

Chronic atrophic candida infection in the mouth

3.2

6.8

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

3.3

6.8

K29.3

ICD-10 Finland

Chronic superficial gastritis

1.5

6.8

204

1380

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

2.7

6.8

131

N05CF02

ATC

zolpidem; oral

1.2

6.8

901

7556

R78

ICPC

Acute bronchitis/bronchiolitis

1.7

6.8

115

680

C83.1

ICD-10 Finland

Mantle cell lymphoma

2.8

6.8

120

M01AX17

ATC

nimesulide; oral

1.2

6.8

1550

13640

B05DA

ATC

Isotonic solutions

2.3

6.8

197

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

2.0

6.8

348

J92

ICD-10 Finland

Pleural plaque

6.1

6.8

XV5WT, ,

NOMESCO Finland

40.1

6.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.3

6.8

361

2706

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.2

6.7

744

6121

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.2

6.7

1163

9995

RT274, ,

NOMESCO Finland

4.3

6.7

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

2.5

6.7

161

L29.9

ICD-10 Finland

Pruritus, unspecified

1.6

6.7

137

850

A10AA01, ,

ATC

1.7

6.7

115

682

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

1.6

6.7

131

804

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

2.4

6.7

186

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.6

6.7

132

813

D69.0

ICD-10 Finland

Allergic purpura

2.4

6.7

168

4120B

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]

1.8

6.6

506

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.5

6.6

192

1290

P70

ICPC

Dementia

0.5

6.6

1203

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.0

6.6

323

R07.1

ICD-10 Finland

Chest pain on breathing

1.9

6.6

399

L05

ICPC

Flank/axilla symptom/complaint

1.4

6.6

334

2481

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

0.8

6.6

517

6485

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.4

6.6

338

2517

XG430

NOMESCO Finland

Spiroegometry

7.8

6.6

N06AX21

ATC

duloxetine; oral

1.3

6.6

554

4418

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.4

6.6

314

2312

E000006, ,

ATC

1.3

6.6

361

2717

K11.2

ICD-10 Finland

Sialoadenitis

1.6

6.6

161

1044

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.3

6.6

200

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

2.3

6.6

200

J01DC02

ATC

cefuroxime; systemic

1.4

6.5

248

1756

OAA67, ,

SPAT

0.7

6.5

211

3021

J14

ICD-10 Finland

Pneumonia due to Haemophilus influenzae

8.7

6.5

GX1P5

NOMESCO Finland

Nocturnal CO2 monitoring

8.7

6.5

-44

ICPC

Preventive immunization/medic

1.3

6.5

534

4244

GX1R5

NOMESCO Finland

Peak expiratory flow (PEF) measurement

10.0

6.5

Z54.8

ICD-10 Finland

Convalescence following other treatment

3.0

6.5

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

2.1

6.5

285

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.5

6.5

203

1386

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

6.5

1918

17198

A91

ICPC

Abnormal result investigation NOS

1.4

6.5

278

2012

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.5

6.5

189

1273

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

1.7

6.5

103

599

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

3.6

6.5

AP1

Catheterization of the left side of the heart

1.7

6.5

114

682

GD1AA, ,

SPAT

1.3

6.5

427

3302

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

3.1

6.4

F61.0

ICD-10 Finland

Mixed personality disorders

2.1

6.4

253

R01AD01

ATC

beclometasone; nasal

1.2

6.4

785

6527

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.2

6.4

240

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

1.8

6.4

446

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

2.1

6.4

273

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

1.7

6.4

108

638

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

3.4

6.4

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

2.8

6.4

107

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

1.8

6.4

447

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

1.7

6.4

117

707

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.6

6.4

135

846

X58

ICD-10 Finland

Exposure to other specified factors

1.2

6.4

701

5766

N05BA01

ATC

diazepam; systemic, rectal

1.2

6.4

752

6232

NDU20

NOMESCO Finland

Removal of internal fixation device from wrist or hand

1.8

6.4

550

TPX15

NOMESCO Finland

Removal of vascular injection port

2.8

6.4

113

R4180

NOMESCO Finland

Podiatric therapy

1.9

6.4

363

R5599

NOMESCO Finland

Other rehabilitation service

1.6

6.4

148

949

A03FA02

ATC

cisapride; oral, rectal

1.3

6.3

472

3708

ZYC03

NOMESCO Finland

Remote contact, text-based

2.4

6.3

166

M60.9

ICD-10 Finland

Myositis, unspecified

2.4

6.3

160

G73.7*M35.0

ICD-10 Finland

Myopathy in sicca syndrome [Sjögren]

6.5

6.3

L04AC14

ATC

sarilumab; systemic

8.1

6.3

D84.9

ICD-10 Finland

Immunodeficiency, unspecified

8.1

6.3

A10BH01

ATC

sitagliptin; oral

1.2

6.3

633

5155

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

1.9

6.3

378

E87.5

ICD-10 Finland

Hyperkalaemia

1.6

6.3

125

771

XCK10

NOMESCO Finland

Photography of fundus of eye

1.2

6.3

640

5220

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

2.0

6.3

330

K51.8

ICD-10 Finland

Other ulcerative colitis

2.0

6.3

344

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

2.6

6.3

137

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

2.6

6.3

137

XG413

NOMESCO Finland

Spirometry with oscillometry

18.0

6.3

AP2

Catheterization of the right side of the heart

2.7

6.3

114

I20.00

ICD-10 Finland

Unstable angina

1.4

6.3

228

1604

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

2.5

6.3

143

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

2.9

6.2

JAH00

NOMESCO Finland

Laparotomy

1.5

6.2

167

1105

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.3

6.2

353

2671

L04AK01

ATC

leflunomide; oral

2.7

6.2

120

K93

ICPC

Pulmonary embolism

2.0

6.2

331

C09CA01

ATC

losartan; oral

1.2

6.2

1742

15555

J34.2

ICD-10 Finland

Deviated nasal septum

1.4

6.2

255

1833

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.4

6.2

282

2063

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.4

6.2

234

1658

E000007, ,

ATC

1.4

6.2

244

1742

N39.1

ICD-10 Finland

Persistent proteinuria, unspecified

2.5

6.2

150

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.5

6.2

161

1060

D02AX

ATC

Other emollients and protectives

1.6

6.1

144

925

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

3.5

6.1

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

2.2

6.1

206

ECB20

NOMESCO Finland

Oral alveoplasty

2.0

6.1

326

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

1.5

6.1

157

1029

G04BE08

ATC

tadalafil; oral

3.2

6.1

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

5.7

6.1

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

1.8

6.1

461

J15.2

ICD-10 Finland

Pneumonia due to staphylococcus

7.7

6.1

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

1.9

6.1

411

RK220, ,

NOMESCO Finland

3.0

6.1

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

1.6

6.1

136

864

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.5

6.1

150

975

K76.9

ICD-10 Finland

Liver disease, unspecified

1.9

6.1

390

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

1.6

6.1

127

794

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

2.8

6.1

NDG71

NOMESCO Finland

Arthrodes of first MP joint

3.8

6.1

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.9

6.0

405

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

6.0

1486

13140

1500

FHL

Thoracoscopy

10.0

6.0

ZXX09

NOMESCO Finland

Extent of procedure, more than 8 units

6.7

6.0

M31.1

ICD-10 Finland

Thrombotic microangiopathy

6.7

6.0

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

1.8

6.0

500

QDB00

NOMESCO Finland

Suture of skin of lower limb

2.4

6.0

164

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.3

6.0

477

3779

I70.1

ICD-10 Finland

Atherosclerosis of renal artery

2.5

6.0

134

N03AX09

ATC

lamotrigine; oral

1.5

6.0

158

1042

R51.80

ICD-10 Finland

Headache

1.2

6.0

699

5785

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3017181) Myelocytes/100 leukocytes in Blood

1529

5500

3.20

323.31

5.8

3.9

0.88

0.98

0.93

686

2005

(3000492) Spirometry study

1451

5093

3.26

319.31

2.7

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

386

433

9.32

314.98

2.0

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1422

4969

3.27

314.95

5.6

3.7

0.62

0.72

0.98

611

1705

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

481

702

7.23

314.82

3.5

3.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

360

368

10.20

314.78

2.0

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

359

367

10.20

313.89

2.0

1.4

—

(3006315) Basophils [#/volume] in Blood

5553

31209

3.58

307.65

11.2

5.4

0.04

e9/l

7.98

5071

26521

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

867

863

11.15

307.65

2.0

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1268

3392

4.26

307.65

2.2

1.8

1.11

1.40

g/l

5.02

1177

3026

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2205

8246

3.32

307.65

2.5

1.7

—

(3018010) Neutrophils/100 leukocytes in Blood

5233

29563

3.25

307.65

11.6

5.6

60.49

58.30

31.25

5108

27348

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

797

1544

5.62

307.65

1.8

1.5

0.23

0.24

g/l

2.05

767

1461

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

713

929

8.33

307.65

1.4

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

1124

2999

4.20

307.65

1.6

1.2

251.57

246.38

u/ml

0.06

1051

2735

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1252

1505

9.68

307.65

1.8

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

756

1257

6.54

307.65

1.3

1.2

13.17

7.22

u/ml

1.16

155

207

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

782

963

8.90

307.65

1.8

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

655

704

10.05

307.65

2.4

1.5

—

(3006504) Eosinophils/100 leukocytes in Blood

5264

29277

3.36

307.65

12.0

5.7

2.79

2.87

1.64

5142

27016

(3013115) Eosinophils [#/volume] in Blood

5636

32215

3.57

307.65

12.0

5.6

0.21

0.20

e9/l

7.06

5197

27704

(3001604) Monocytes [#/volume] in Blood

5548

31099

3.59

307.65

11.2

5.4

0.67

0.62

e9/l

29.23

5065

26415

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1708

2598

8.10

307.65

1.6

1.5

14.52

16.75

u/ml

0.15

(3019198) Lymphocytes [#/volume] in Blood

5574

31866

3.50

307.65

11.4

5.5

1.88

1.89

e9/l

0.17

5144

27651

(3013637) Mi-2 Ab [Presence] in Serum

245

107

23.59

307.65

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

753

1241

6.60

307.65

1.3

1.2

7.36

5.27

u/ml

0.23

129

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

635

884

7.72

307.65

1.2

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2801

11966

3.07

307.65

2.7

1.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2275

8412

3.39

307.65

1.3

1.2

26.15

13.32

u/ml

2.65

675

3054

(3027801) Oxygen [Partial pressure] in Arterial blood

2135

8528

3.05

307.65

9.8

6.8

10.20

12.06

kpa

73.77

2043

8073

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

534

658

8.63

307.65

2.5

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

5382

29178

3.61

307.65

12.9

6.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

5288

30050

3.26

307.65

12.2

5.9

24.34

26.36

32.95

5167

27825

(3019069) Monocytes/100 leukocytes in Blood

5273

29451

3.34

307.65

12.4

6.0

8.87

8.88

0.05

5153

27218

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2443

8998

3.47

307.65

1.3

61.73

36.58

iu/ml

5.73

850

2764

(3013650) Neutrophils [#/volume] in Blood by Automated count

5718

36274

3.05

307.65

15.1

8.6

4.76

4.28

e9/l

39.11

5281

31302

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

840

1034

8.96

307.65

1.2

49.99

0.55

u/ml

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

814

1617

5.49

307.65

2.5

2.2

126.41

127.69

g/l

0.46

381

1222

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

696

1035

7.27

307.65

1.3

1.2

17.47

1.97

u/ml

1.89

(3003396) Base excess in Arterial blood by calculation

2118

8496

3.03

307.65

9.9

6.8

1.51

1.08

mmol/l

4.61

1758

6644

(3019060) Gas panel - Arterial blood

1599

4981

3.77

307.65

5.7

4.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

800

1603

5.44

307.65

1.8

1.5

1.19

1.17

g/l

0.92

773

1517

(3037692) Legionella sp identified in Specimen by Organism specific culture

383

180

22.30

307.65

1.9

1.3

—

(3023419) Bacteria identified in Sputum by Culture

845

971

9.62

307.65

2.6

2.4

—

(3042631) Mycobacterium sp identified in Specimen

711

986

7.82

307.65

2.9

2.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1108

1501

8.41

307.65

2.2

1.5

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1613

4298

4.45

307.65

4.0

2.6

10.28

10.63

g/l

1.85

1540

3895

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1008

1681

6.72

307.65

1.6

1.4

13.22

16.55

iu/ml

0.32

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1065

1865

6.44

307.65

1.3

1.2

1.75

0.91

u/ml

0.88

100

178

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

763

1213

6.85

307.65

1.3

1.2

179.23

126.96

titre

0.21

(3037522) Nuclear Ab [Titer] in Serum

2747

6928

5.53

307.65

1.5

1.3

583.24

505.60

titre

1.25

809

1442

(42529582) MDA5 Ab [Presence] in Serum by Line blot

245

107

23.59

307.65

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2203

8207

3.33

307.65

2.5

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

721

974

8.04

307.65

2.3

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1096

1439

8.67

307.65

2.2

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

726

872

9.06

307.65

2.2

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1244

2027

7.09

307.65

1.8

1.5

302.32

260.66

titre

0.21

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

929

1526

6.76

307.65

1.9

1.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2138

8532

3.06

307.65

9.8

6.8

5.06

kpa

0.11

2044

8091

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

878

373

26.33

307.65

2.0

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1019

1065

10.83

307.65

2.0

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

703

1090

6.98

307.65

11.4

4.7

1298.10

1869.66

iu/ml

0.13

163

154

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

772

1347

6.24

307.65

1.3

1.2

36.51

51.52

u/ml

0.61

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

741

841

9.61

307.65

1.7

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

995

2391

4.61

307.65

1.8

38.57

38.53

u/l

0.02

900

2046

(3023368) Bacteria identified in Blood by Culture

3705

20476

2.51

307.65

6.3

4.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

541

205

28.24

307.65

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

721

974

8.04

307.65

2.3

1.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

245

107

23.59

307.65

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

245

107

23.59

307.65

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

869

1099

8.75

307.65

2.2

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

534

658

8.63

307.65

2.5

1.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1567

2442

7.74

307.65

3.1

2.7

—

(4200892) Spirometry reversibility

1381

4452

3.54

307.65

1.9

1.4

—

(3022096) Basophils/100 leukocytes in Blood

5207

28425

3.41

307.65

11.9

5.7

0.62

0.65

3.51

5088

26205

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

251

148

17.48

305.25

1.3

1.2

—

(3025159) Blasts/100 leukocytes in Blood

1374

4891

3.19

293.60

5.8

3.9

0.24

0.35

0.29

520

1430

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

509

848

6.34

293.37

4.9

2.4

654.67

2341.42

u/ml

1.11

(3000494) Fungus identified in Specimen by Culture

1748

7169

2.84

289.58

2.2

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

404

538

7.86

286.52

2.0

1.5

—

(3021440) Promyelocytes/100 leukocytes in Blood

1415

5218

3.08

283.87

5.8

3.9

0.08

0.12

1.63

567

1732

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

669

1487

4.82

280.58

1.7

1.9

11.02

12.32

mg/l

1.80

623

1360

(3039162) Centromere protein B Ab [Units/volume] in Serum

413

585

7.39

277.36

1.3

1.2

54.20

42.22

u/ml

0.34

(46235355) HIV 1 and 2 tests - Meaningful Use set

1626

6560

2.86

276.64

1.7

1.6

—

(3016502) Oxygen saturation in Arterial blood

1807

7703

2.74

276.63

10.7

7.1

93.81

95.46

19.82

1742

7391

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5071

34606

2.28

260.97

9.6

6.1

11.35

12.27

umol/l

5.26

4923

32771

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

399

593

7.03

256.28

2.0

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

408

633

6.74

251.64

2.0

1.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

368

516

7.43

249.17

1.4

1.3

7.34

6.94

g/l

0.64

251

356

(3024139) IgG subclass 3 [Mass/volume] in Serum

367

516

7.41

247.87

1.4

1.3

0.48

0.42

g/l

1.39

253

359

(3028192) IgG subclass 2 [Mass/volume] in Serum

367

516

7.41

247.87

1.4

1.3

2.96

2.90

g/l

0.21

254

360

(3042936) Bacteria identified in Isolate by Culture

2040

9680

2.49

247.17

2.6

2.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

466

841

5.82

246.89

1.7

1.6

0.94

0.85

g/l

0.53

337

636

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3716

22725

2.19

246.56

4.2

3.1

2058.08

1784.58

ng/l

2.11

3355

19697

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

161

30.41

245.01

3.0

1.8

—

(4062490) Immunoglobulin typing, IgG

365

518

7.34

244.44

1.4

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1100

3835

3.17

240.61

11.1

8.8

24.67

24.26

mmol/l

3.26

1054

3672

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4663

31424

2.17

238.09

10.6

6.1

1.20

1.21

mmol/l

8.98

4405

28404

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

488

951

5.40

237.78

1.4

1.2

59.95

45.10

u/ml

0.95

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

966

3144

3.36

236.57

2.6

1.9

2.10

2.41

ug/l

0.24

885

2727

(3018418) pH of Serum or Plasma

3402

20384

2.17

234.45

6.1

4.1

7.40

0.57

808

3838

(3021589) Normoblasts [#/volume] in Blood

4134

27309

2.07

213.53

19.2

10.0

0.00

e9/l

0.45

3525

22180

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4918

34738

2.09

210.15

11.7

6.8

1.21

mmol/l

5.28

4164

29347

(3004616) Nuclear Ab [Presence] in Serum

376

647

6.05

208.97

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

277

355

8.05

202.50

3.9

3.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

209

188

11.39

199.19

2.0

1.8

51259.74

20305.32

u/ml

0.26

(3013707) Erythrocyte sedimentation rate by Westergren method

6010

46330

2.21

196.96

9.0

4.1

18.57

13.81

mm/h

76.28

5833

42200

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1137

4517

2.77

194.06

5.8

3.7

2.21

1.78

mmol/l

3.45

904

3308

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1171

4746

2.72

192.13

6.1

3.7

5.15

5.14

kpa

0.03

1130

4455

(3009343) pH of Capillary blood

1158

4684

2.72

190.64

6.0

3.7

7.43

7.42

1.58

223

562

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

283

403

7.24

188.63

1.2

1.1

24.96

2.86

u/ml

1.42

(1616796) Gas panel - Central venous blood

594

1635

3.85

186.34

5.5

3.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

288

427

6.96

184.97

1.2

1.1

68.57

35.79

u/ml

1.16

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1502

6995

2.41

183.56

12.3

7.5

122.19

120.13

g/l

3.06

1462

6804

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

286

425

6.94

183.29

1.2

1.1

78.08

76.80

u/ml

0.02

(3007164) IgA [Mass/volume] in Serum or Plasma

1937

10066

2.22

182.80

1.9

1.5

2.81

2.61

g/l

2.70

1404

5782

(3038026) Centromere Ab [Units/volume] in Serum

289

436

6.84

182.61

1.2

39.62

63.73

u/ml

0.49

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2094

11284

2.16

179.96

6.2

3.0

0.82

0.81

mmol/l

0.23

1968

10471

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2364

13407

2.09

177.19

2.5

1.7

1.55

1.42

mg/l

0.84

1955

10407

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

315

546

5.97

173.52

1.7

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

315

546

5.97

173.52

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

315

546

5.97

173.52

1.7

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1445

6779

2.38

172.76

12.6

6.7

11.40

11.01

mmol/l

1.11

1388

6406

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

437

1017

4.49

171.71

1.5

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1198

5179

2.55

171.12

1.7

1.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1211

5288

2.52

169.22

2.1

2.3

338.55

378.91

nmol/l

7.60

1144

4808

(3015235) Bicarbonate [Moles/volume] in Capillary blood

632

1934

3.46

168.81

4.8

3.0

25.27

24.82

mmol/l

1.73

615

1888

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

430

1014

4.43

166.07

1.4

34.83

16.26

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

565

1626

3.66

165.68

1.6

48.65

4.41

iu/ml

0.92

128

384

(3011412) CD3 cells [#/volume] in Blood

304

533

5.89

165.43

2.2

2.1

1.01

1.10

e9/l

0.91

281

480

(3021901) Oxygen saturation in Capillary blood

518

1414

3.85

164.05

4.3

2.7

—

(40767503) Oxygen content in Capillary blood by calculation

550

1566

3.70

163.82

3.5

2.5

15.47

16.03

2.17

323

823

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3045

19396

1.92

160.33

5.0

3.1

35.56

35.90

u/l

0.07

2909

18232

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

270

440

6.32

158.24

1.4

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

391

889

4.57

158.07

1.5

1.4

128.65

120.91

u/ml

0.19

192

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1012

4190

2.62

157.28

11.8

6.9

25.06

24.78

mmol/l

1.37

1000

4147

(3042733) HLA Ab [Presence] in Serum

158

133

12.10

157.09

4.3

4.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

867

3323

2.81

156.81

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

573

1734

3.48

155.45

5.3

3.1

7.65

7.95

kpa

4.25

560

1689

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1243

5697

2.40

155.31

1.7

1.5

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1092

4767

2.50

151.61

10.0

6.8

25.03

24.52

mmol/l

4.10

1050

4532

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

563

1734

3.42

148.44

3.5

2.3

3.86

3.58

g/l

3.35

549

1642

(3024561) Albumin [Mass/volume] in Serum or Plasma

4192

30045

1.83

148.21

7.0

4.8

33.22

34.74

g/l

50.99

3933

27688

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6157

49962

2.03

146.55

14.2

7.5

80.45

80.59

u/l

0.07

6010

46750

(3022217) INR in Platelet poor plasma by Coagulation assay

4636

34352

1.84

146.12

20.3

18.8

1.31

1.36

inr

3.81

1525

9611

(3002582) Erythrocytes [#/volume] in Urine

3209

21381

1.84

142.15

4.9

3.5

85.83

107.31

e6/l

0.23

2625

16726

(36304419) Bacteria [Presence] in Urine

2902

18741

1.86

142.14

4.6

3.3

—

(40758558) Short blood count panel - Blood

2570

15969

1.90

142.03

10.8

6.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1730

9376

2.08

141.89

9.3

5.6

1.07

1.04

mmol/l

4.01

1624

8640

(1175426) CD3 cells/100 lymphocytes in Blood

249

418

6.12

141.59

2.1

2.0

71.97

71.00

0.35

239

394

(40759836) Histone Ab [Presence] in Serum by Immunoblot

223

337

6.78

140.53

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

223

337

6.78

140.53

1.3

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1626

8644

2.11

140.22

4.6

4.0

266.69

248.08

u/l

4.20

1544

8105

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

223

338

6.76

140.13

1.3

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

244

408

6.14

139.29

2.1

2.0

16.31

16.80

0.23

238

394

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

223

341

6.70

138.96

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

223

341

6.70

138.96

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

223

341

6.70

138.96

1.3

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

176

209

8.59

136.80

3.5

1.7

46.22

58.60

ug/l

1.20

176

200

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1802

10032

2.03

136.67

3.4

2.6

20.94

21.78

1.61

1523

8414

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1362

6823

2.20

136.46

4.2

3.0

268.46

239.54

ng/l

1.28

1275

6262

(3030467) Casts [#/volume] in Urine by Automated count

2978

19575

1.83

136.38

4.7

3.3

0.42

0.48

e6/l

0.82

2389

15228

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

238

397

6.15

136.19

2.2

2.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1976

11414

1.97

134.65

3.3

2.6

11.58

12.31

umol/l

4.32

1869

10515

(3001964) Herpes simplex virus Ag [Presence] in Specimen

154

158

9.92

133.83

2.7

1.3

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1866

10611

1.99

132.78

3.3

2.5

2.24

2.27

g/l

1.55

1739

9729

(3024471) HLA-A [Type]

144

136

10.76

132.66

1.0

—

(3024932) HLA-DR beta [Type]

142

132

10.93

132.24

1.0

1.1

—

(3018095) Leukocytes [#/volume] in Urine

3477

24149

1.78

130.87

5.8

3.9

94.73

111.04

e6/l

0.41

2715

17773

(3027315) Oxygen [Partial pressure] in Blood

517

1654

3.27

127.87

7.3

4.1

8.23

8.44

kpa

1.94

507

1611

(3012501) Base excess in Blood by calculation

511

1647

3.25

124.79

7.3

4.1

2.79

2.62

mmol/l

0.64

393

1118

(3013290) Carbon dioxide [Partial pressure] in Blood

511

1648

3.24

124.67

7.3

4.1

5.03

4.98

kpa

0.65

501

1606

(3000850) Epithelial cells [#/volume] in Urine

2409

15164

1.84

124.47

3.8

2.7

4.46

4.59

e6/l

0.18

2222

13575

(3020630) Protein [Mass/volume] in Serum or Plasma

1265

6397

2.16

122.68

2.4

2.5

65.86

66.03

g/l

0.29

1175

5708

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

580

2053

2.97

120.49

1.7

—

(3010421) pH of Blood

552

1903

3.04

120.15

7.2

4.0

7.42

0.77

515

1720

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1083

5189

2.26

119.89

1.9

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

205

335

6.25

119.70

1.5

1.3

1.74

2.14

u/ml

0.20

138

192

(3026782) Osmolality of Urine

2305

14466

1.84

119.30

4.0

3.0

525.05

548.30

mosm/kgh2o

6.99

2077

12398

(3013826) Glucose [Moles/volume] in Serum or Plasma

5063

39739

1.75

119.05

9.1

4.8

6.93

6.86

mmol/l

1.26

4878

37389

(3023420) DNA double strand Ab [Units/volume] in Serum

250

495

5.18

118.99

1.9

1.3

20.33

26.36

iu/ml

0.62

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

511

1697

3.15

118.60

3.5

2.1

89.13

88.40

0.31

498

1628

(3000991) Gas panel - Venous blood

1206

6060

2.17

118.56

12.7

7.8

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1090

5333

2.21

114.29

2.2

2.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

194

318

6.23

112.92

1.7

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

192

318

6.16

110.60

1.7

1.8

—

(3002032) Base excess in Venous blood by calculation

1308

6952

2.05

110.24

5.5

3.7

2.26

1.90

mmol/l

2.66

1124

5816

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

168

244

7.01

109.80

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

168

244

7.01

109.80

1.7

1.9

—

(40757373) Influenza virus identified in Isolate

126

129

9.91

109.63

2.7

1.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

876

3977

2.35

109.55

15.7

9.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

466

1539

3.15

109.02

3.7

2.4

211.56

203.24

1.08

444

1465

(3010375) cycloSPORINE [Mass/volume] in Blood

166

240

7.04

108.95

42.8

23.5

150.82

105.61

ug/l

8.66

136

196

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3539

25606

1.69

108.21

2.9

2.2

77.78

78.85

nmol/l

1.43

3262

22397

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

167

246

6.91

107.73

1.7

1.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1306

6994

2.04

107.58

5.5

3.7

5.89

5.82

kpa

1.38

1255

6777

(3010503) CD19 cells [#/volume] in Blood

199

352

5.77

107.13

2.3

2.2

0.10

0.18

e9/l

0.90

194

337

(3012544) pH of Venous blood

1338

7246

2.02

106.76

5.5

3.7

7.39

7.38

0.45

(3026250) Tacrolimus [Mass/volume] in Blood

149

196

7.73

106.34

40.0

32.4

7.95

7.29

ug/l

2.16

134

175

(3014111) Lactate [Moles/volume] in Serum or Plasma

1218

6389

2.07

106.06

11.2

6.6

1.42

1.39

mmol/l

0.46

1176

6197

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

340

935

3.75

105.98

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

168

254

6.73

105.77

1.4

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

324

863

3.87

105.73

1.3

1.2

328.96

283.77

u/ml

1.12

214

527

(3028271) Lactate [Moles/volume] in Capillary blood

382

1153

3.43

103.42

2.4

1.9

1.66

1.72

mmol/l

0.56

374

1126

(3027945) Reticulocytes/100 erythrocytes in Blood

1552

8970

1.91

101.88

3.5

2.4

1.95

1.75

10.16

1380

7821

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

194

360

5.50

99.21

2.1

2.2

482.38

500.86

e6/l

0.16

162

300

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

213

432

5.04

98.57

1.3

1.2

105.00

123.85

titre

0.23

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

213

432

5.04

98.57

1.3

1.2

126.60

140.87

titre

0.14

(3022313) Gas panel - Capillary blood

763

3412

2.37

98.33

6.5

3.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

284

727

4.01

97.93

1.3

1.2

4.19

3.67

u/ml

0.10

112

224

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

215

447

4.92

96.65

2.2

2.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2156

13962

1.75

96.59

5.5

4.1

420.70

484.51

ng/l

0.32

1906

11864

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

229

504

4.65

96.12

1.4

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

208

433

4.91

93.36

1.1

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

386

1249

3.20

93.28

1.3

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

183

342

5.45

92.86

2.2

0.21

0.23

e9/l

0.56

163

297

(3028433) Virus identified in Specimen by Culture

139

198

7.13

92.47

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

260

657

4.06

91.23

1.2

1.1

117.45

114.55

0.62

247

574

(3036489) Thrombin time

546

2174

2.62

90.06

3.3

1.9

21.97

21.88

0.08

502

1934

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

137

199

6.99

89.52

2.1

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

269

708

3.90

89.20

1.3

1.2

3.29

4.54

u/ml

1.06

157

300

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2976

21333

1.63

89.08

3.3

2.1

164.09

224.45

u/l

4.00

2812

19868

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1169

6404

1.97

88.91

2.3

2.1

0.21

0.20

g/l

1.31

1090

5909

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

911

4561

2.13

88.77

2.0

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

5359

44310

1.64

88.27

6.7

4.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2559

17712

1.66

87.77

4.7

2.8

3287.53

5651.49

umol/l

2.47

2276

15159

(3023520) Reticulocytes [#/volume] in Blood

1214

6780

1.93

87.09

3.4

2.5

73.89

67.85

e9/l

5.46

877

5194

(3017569) Oxygen content in Arterial blood

182

360

5.15

86.68

2.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

739

3453

2.26

85.47

5.4

3.9

24.36

24.06

mmol/l

1.73

722

3369

(3013293) Extractable nuclear Ab [Presence] in Serum

12.47

85.47

1.5

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

439

1609

2.83

85.02

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

438

1609

2.82

84.45

1.5

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

632

2777

2.39

84.32

4.0

2.8

0.32

0.34

u/ml

1.30

389

1580

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1768

11197

1.74

83.86

2.9

2.0

30.24

30.18

0.13

1723

10848

(3033658) Prothrombin time (PT) actual/Normal

2412

16614

1.65

83.40

6.5

4.0

84.46

85.02

0.47

2363

16193

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

212

495

4.37

82.59

1.2

1.1

94.85

94.51

0.06

204

456

(3014007) Fractional oxyhemoglobin in Arterial blood

903

4626

2.07

82.48

14.2

8.6

92.33

93.88

12.19

896

4607

(21494814) CD8 cells/100 lymphocytes in Specimen

140

227

6.26

82.37

2.1

2.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

101

113

9.04

82.22

1.6

1.8

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

200

450

4.53

81.67

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

252

685

3.77

79.78

1.2

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3108

23020

1.57

78.20

4.3

3.4

2.34

2.35

mmol/l

5.38

2822

19824

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3371

25478

1.56

77.32

3.7

2.9

206.77

155.28

ug/l

10.41

3098

23059

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

10.47

77.11

1.3

1.1

41.41

46.07

mg/l

0.27

(3009871) Measles virus Ab [Titer] in Serum

101

124

8.24

76.38

1.4

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

209

518

4.12

75.27

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2561

18262

1.59

75.11

2.6

2.3

3.22

3.06

mg/l

2.53

2245

15397

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

196

465

4.30

74.80

2.3

—

(3035350) Ketones [Presence] in Urine by Test strip

3935

30983

1.53

73.66

5.0

4.0

0.00

estimate

2.77

1108

6232

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

879

4639

2.01

73.53

14.4

8.5

1.39

1.34

0.91

867

4608

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1041

5827

1.90

73.24

5.7

3.9

1.22

1.23

mmol/l

3.79

953

5047

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

876

4627

2.00

73.08

14.5

8.6

0.64

0.67

1.07

865

4592

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

219

578

3.87

72.31

1.1

1.78

2.53

iu/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

3914

30885

1.53

71.81

6.7

5.2

0.00

estimate

0.80

1061

5743

(3009261) Glucose [Presence] in Urine by Test strip

3951

31277

1.52

71.14

5.0

4.0

0.00

estimate

1.60

1023

5576

(3046861) Legionella sp Ag [Presence] in Urine

18.18

69.81

1.1

1.0

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

738

3727

2.08

69.52

2.0

1.6

1.63

1.56

g/l

1.06

624

3157

(3031040) Bacteria [#/volume] in Urine by Automated count

5158

43360

1.54

69.05

6.3

4.9

1366.68

1808.85

e6/l

0.24

721

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

819

4321

2.00

68.33

1.7

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

167

376

4.52

68.15

2.3

2.2

561.56

635.81

e6/l

0.87

154

358

(3019977) pH of Arterial blood

176

418

4.28

67.08

2.9

2.4

7.43

7.42

0.59

106

135

(3034860) Kappa light chains.free [Mass/volume] in Serum

559

2565

2.27

67.05

2.9

3.1

64.82

84.00

mg/l

0.40

410

2108

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

152

322

4.79

66.84

2.5

2.6

39.25

37.37

0.47

181

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

650

3174

2.14

66.80

8.1

5.0

1.77

1.61

4.32

610

2977

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

557

2563

2.26

66.35

2.9

3.1

45.34

52.68

mg/l

0.59

406

2104

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1217

7361

1.77

66.08

4.9

3.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

145

300

4.90

65.58

1.1

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

1007

5774

1.85

65.22

4.2

3.2

4.68

4.48

kpa

1.75

960

5573

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

542

2497

2.26

64.33

2.9

3.1

3.45

3.00

ratio

0.12

195

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3485

27262

1.50

63.89

5.4

4.1

95.50

74.00

ng/l

0.17

2804

20798

(40761536) Microorganisms panel - Urine sediment

947

5372

1.87

63.35

5.5

4.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1686

11264

1.63

62.81

4.2

3.2

1.69

2.03

e6/l

1.49

947

6404

(3020891) Body temperature

609

2968

2.14

62.79

6.2

4.7

—

(3047181) Lactate [Moles/volume] in Blood

510

2315

2.29

62.68

10.6

5.8

1.40

1.33

mmol/l

1.03

469

2051

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

10.08

61.02

1.2

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

148

331

4.54

60.92

2.0

1.6

6.06

6.82

u/l

0.54

131

277

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

237

743

3.26

60.23

1.1

1.56

1.55

g/l

0.25

210

664

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

132

6.88

58.32

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

1248

7851

1.70

58.23

2.2

1.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

541

2591

2.17

58.22

3.4

2.2

371.56

666.42

ug/l

1.85

515

2453

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

139

6.68

57.99

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1183

7358

1.71

57.50

3.3

2.7

9.59

9.33

umol/l

0.13

1023

6410

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

107

190

5.69

57.41

2.0

1.9

30.82

29.89

0.21

101

175

(3006245) CD3-CD19+ cells/100 cells in Blood

106

189

5.67

56.63

2.0

9.73

11.92

0.73

170

(3007930) Methemoglobin/Hemoglobin.total in Blood

616

3139

2.04

56.23

8.6

5.0

0.87

0.88

0.21

576

2946

(3037756) Immunofixation for Serum or Plasma

398

1703

2.41

55.93

1.6

1.5

—

(3034426) Prothrombin time (PT)

151

6.29

55.86

1.1

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1744

12063

1.57

55.16

3.8

3.0

1.04

1.14

e6/l

0.55

1005

7150

(3018572) Chloride [Moles/volume] in Blood

387

1662

2.40

53.93

11.3

6.7

103.97

105.02

mmol/l

4.03

355

1488

(3039000) Anion gap in Blood

387

1662

2.40

53.93

11.3

6.7

11.52

11.23

mmol/l

0.89

355

1488

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2735

20891

1.47

53.70

3.1

2.6

61.56

64.00

u/l

0.22

2554

19226

(40760888) Immunoglobulin light chains.free panel - Serum

424

1919

2.28

52.34

2.8

3.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

310

1222

2.60

51.86

3.9

3.5

1.62

1.65

0.05

290

1056

(3015736) pH of Urine

3144

24854

1.44

50.63

4.2

3.7

5.79

5.80

0.08

110

1166

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

312

1253

2.55

50.23

1.4

1.3

—

(4035726) Immunohistochemistry procedure

964

5867

1.73

50.21

1.5

1.4

—

(3018405) Lactate [Moles/volume] in Arterial blood

535

2701

2.05

49.96

5.0

3.9

1.42

mmol/l

0.00

525

2656

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

549

2803

2.03

49.70

2.4

2.3

3.15

2.96

g/l

4.35

508

2463

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3781

30973

1.42

49.61

3.0

2.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

567

2932

2.01

49.53

7.4

4.1

25.02

24.76

mmol/l

1.38

537

2661

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

548

2820

2.01

48.51

2.4

2.2

10.45

10.24

g/l

0.46

502

2455

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

460

2218

2.14

48.50

2.4

2.2

0.07

0.05

g/l

0.22

429

2004

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

577

3024

1.98

48.49

2.4

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

577

3026

1.98

48.40

2.4

2.2

7.88

7.43

g/l

7.11

536

2682

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

576

3019

1.98

48.40

2.4

2.2

3.89

3.70

g/l

1.54

533

2681

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

436

2063

2.18

48.23

2.5

2.2

0.00

g/l

1.04

405

1855

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

323

1350

2.45

47.75

1.3

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

429

2026

2.18

47.68

2.5

2.2

0.00

g/l

-0.00

404

1848

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

504

2543

2.05

47.09

2.5

2.3

0.66

1.04

g/l

1.71

446

2139

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

324

1376

2.41

46.25

1.8

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

336

1457

2.36

45.77

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

298

1229

2.48

45.34

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2135

16000

1.46

44.37

5.1

3.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

114

268

4.30

44.11

1.1

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

135

5.82

43.03

1.1

1.0

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

462

2336

2.04

42.86

2.4

2.1

35.92

37.29

g/l

4.88

420

1987

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

365

1689

2.22

42.63

3.6

2.9

1.87

1.69

mg/l

3.04

336

1506

(3004119) Hemoglobin [Mass/volume] in Venous blood

764

4566

1.74

42.08

5.1

3.3

123.60

127.70

g/l

5.27

738

4450

(3026008) Bacteria identified in Urine by Culture

2725

21527

1.40

41.70

3.8

3.4

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

11.06

41.50

1.0

1.1

5.50

2.57

u/ml

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

241

945

2.60

40.76

8.1

6.4

12.22

12.07

mg/l

0.22

223

865

(3021788) Differential panel - Synovial fluid

281

1199

2.39

39.69

1.7

1.4

—

(3023183) Ammonium ion [Moles/volume] in Plasma

319

1442

2.26

39.43

2.7

2.5

32.24

34.04

umol/l

0.67

301

1272

(3007566) Smooth muscle Ab [Titer] in Serum

326

1491

2.24

39.17

1.2

105.13

114.13

titre

0.14

109

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

433

2209

2.02

39.14

1.5

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

5730

51461

1.40

38.45

37.5

19.6

15.25

15.33

0.62

5681

50424

(3034770) Mitochondria Ab [Titer] in Serum

323

1496

2.21

37.63

1.2

1203.57

940.83

titre

0.39

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

848

5394

1.64

36.75

5.1

3.8

116.99

97.32

ng/l

2.85

747

4551

(3027273) Bicarbonate [Moles/volume] in Venous blood

635

3740

1.76

36.64

5.2

3.5

25.56

25.13

mmol/l

2.02

604

3627

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

181

658

2.79

35.55

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

409

2126

1.97

35.03

4.4

3.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

212

4.28

34.80

1.1

21.92

5.65

u/ml

0.54

(3029937) Albumin [Presence] in Urine by Test strip

2192

17104

1.39

34.58

5.5

4.4

0.00

estimate

1.73

988

5429

(3036782) Glucose [Moles/volume] in Pleural fluid

202

789

2.60

34.47

1.4

6.69

6.39

mmol/l

0.65

186

723

(3000012) Reticulocyte production index

266

1183

2.29

34.18

2.6

2.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

219

899

2.48

33.70

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

162

4.73

33.30

2.4

2.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

174

645

2.74

32.95

1.2

—

(40768797) Stomach Pathology biopsy report

1243

8831

1.48

32.63

1.3

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

358

1821

2.01

32.60

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

266

1208

2.24

32.53

1.5

31.89

31.36

g/l

0.26

234

1071

(3042111) Morphology [Interpretation] in Bone marrow Narrative

278

1292

2.19

32.13

1.7

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

195

778

2.54

31.88

4.7

4.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

236

1036

2.32

31.28

1.2

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

100

275

3.67

31.28

1.2

1.1

1.05

1.06

ratio

0.26

(3044889) 12 lead EKG panel

5028

44831

1.33

31.12

5.7

4.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1741

13288

1.40

30.72

3.1

3.2

2.48

2.46

mmol/l

7.97

1550

11533

(3004451) EKG impression Narrative

121

381

3.21

30.67

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

161

600

2.72

30.21

1.6

1.5

14.34

13.09

u/l

1.24

154

575

(3000060) B lymphocytes [#/volume] in Blood

121

5.16

30.12

2.1

2.0

782.50

1299.00

e6/l

0.23

(3043409) Potassium [Moles/volume] in Arterial blood

417

2293

1.86

30.12

5.8

4.2

3.98

3.91

mmol/l

2.00

411

2268

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

248

1133

2.23

29.91

4.1

3.3

—

(3012441) Differential panel - Pleural fluid

213

912

2.37

29.90

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

319

1611

2.02

29.64

1.8

1.7

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

109

5.35

29.39

1.4

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

357

1890

1.93

28.96

1.6

1.3

—

(3024928) Oxygen saturation in Venous blood

302

1508

2.04

28.95

4.5

2.9

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1910

14989

1.36

27.98

4.3

3.9

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

194

825

2.39

27.68

1.3

424.27

368.80

u/l

0.38

182

780

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1516

11482

1.40

27.60

1.3

1.2

1.28

1.88

u/ml

1.96

368

2873

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

207

909

2.31

27.45

1.2

1.3

181.89

201.56

miu/ml

0.29

333

(40768446) Kidney Pathology biopsy report

202

3.94

27.45

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

881

6032

1.52

27.35

2.9

2.4

45.66

45.67

u/l

0.00

781

5114

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

152

4.44

27.25

1.1

—

(3025941) Bacteria identified in Stool by Culture

526

3196

1.69

26.95

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

161

636

2.56

26.93

1.3

14.54

13.14

u/l

0.34

142

577

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

146

550

2.69

26.86

1.9

1.8

4.65

4.62

mg/l

0.02

136

522

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6571

61476

1.39

26.72

34.6

16.6

26.19

26.75

mg/l

0.75

6146

50056

(3010838) Calcium [Moles/time] in 24 hour Urine

225

1039

2.20

26.46

1.8

4.40

4.75

mmol/24h

0.89

201

884

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2829

23657

1.30

26.29

5.3

4.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2132

17164

1.33

25.99

1.8

1.6

18.96

20.04

nmol/l

2.80

1893

14536

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

5.34

25.82

1.3

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

510

3129

1.67

25.17

2.7

1.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

198

3.81

24.95

1.4

2.0

193.44

162.44

1.59

185

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

164

678

2.45

24.94

1.2

61.09

66.86

u/l

0.55

149

604

(3016650) Hepatitis A virus Ab [Presence] in Serum

188

828

2.30

24.80

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

114

395

2.91

24.58

1.7

1.9

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

27.60

24.41

1.0

—

(3045142) Bone marrow Pathology biopsy report

183

803

2.31

24.36

1.5

1.3

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

8.23

24.35

1.2

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

8.23

24.35

1.2

1.0

—

(40768806) Pleura Pathology biopsy report

201

919

2.22

24.25

1.5

1.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4226

37430

1.28

24.24

4.4

3.1

69.03

54.14

u/l

9.45

3931

34064

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

5.58

23.92

1.6

1.5

100.21

92.63

au/ml

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

115

4.72

23.76

1.6

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

136

4.36

23.56

1.1

1.2

86.50

83.60

0.24

(3019309) Folate [Moles/volume] in Red Blood Cells

1873

14977

1.33

23.51

1.9

1.8

1188.50

1158.92

nmol/l

0.64

1430

11120

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

185

834

2.25

23.12

1.7

1.5

58.74

62.07

0.53

113

548

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

5.25

22.90

1.3

1.2

109.94

1025.94

ng/l

0.50

(3045788) Cell count panel - Pleural fluid

181

816

2.25

22.62

1.5

—

(40762365) Oxygen content in Arterial blood by calculation

141

4.21

22.50

2.2

2.7

15.06

14.66

ml/dl

0.37

133

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

140

4.17

21.84

1.1

1.3

85.53

83.08

0.16

(3050794) Legionella sp Ab [Presence] in Serum

6.51

21.70

1.1

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

150

638

2.38

21.49

1.9

1.4

36.54

26.98

2.28

410

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

540

3495

1.58

21.44

5.4

4.1

46.74

47.39

0.24

531

3450

(3044941) Cell count panel - Synovial fluid

213

1051

2.05

21.17

1.7

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

186

874

2.16

21.02

11.5

15.7

7.34

7.48

mmol/l

0.21

165

710

(3051651) Icteric interference index of Serum or Plasma

111

413

2.71

21.02

6.2

3.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

784

5559

1.46

20.18

1.7

1.68

1.55

3.94

662

4696

(3017732) Neutrophils [#/volume] in Blood

615

4162

1.52

19.96

3.4

3.2

4.99

5.40

e9/l

0.49

508

3133

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

201

3.45

19.93

1.0

1.1

98.60

93.31

0.96

148

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

7.59

19.93

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

297

1674

1.80

19.84

1.8

1.5

12732.93

15366.28

e6/l

0.41

227

1197

(3023199) Leukocytes [#/volume] in Pleural fluid

211

1063

2.01

19.83

1.5

3611.63

2205.35

e6/l

0.36

145

784

(3034891) Synovial lining cells/100 cells in Synovial fluid

309

2.93

19.81

1.8

1.4

4.09

3.63

0.15

(3022493) Free Hemoglobin [Mass/volume] in Plasma

279

3.00

18.98

7.0

3.9

63.46

65.25

mg/l

0.09

194

(40768795) Lymph node Pathology biopsy report

143

631

2.29

18.88

1.4

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

149

3.78

18.51

1.7

1.6

8.44

9.62

ug/l

1.18

149

(3019832) Treponema pallidum Ab [Presence] in Serum

371

2273

1.66

18.40

1.6

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

173

3.55

18.38

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

160

751

2.15

18.19

4.2

3.4

57.08

57.27

0.04

145

611

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

447

2881

1.58

18.05

2.4

1.8

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

108

4.28

18.01

2.2

1.7

7.11

9.22

mg/l

1.55

(3009508) Creatinine [Moles/volume] in Urine

2541

21707

1.25

17.97

3.8

3.2

7.01

7.39

mmol/l

5.05

2124

17876

(3028308) Erythrocytes [#/volume] in Pleural fluid

190

958

2.01

17.86

1.5

133726.50

54554.84

e6/l

1.10

107

586

(3012516) Albumin [Mass/volume] in Urine

2486

21226

1.25

17.57

3.8

3.2

710.27

344.26

mg/l

2.55

1695

13788

(3027456) Digoxin [Moles/volume] in Serum or Plasma

303

1781

1.73

17.55

3.2

3.1

0.85

0.82

nmol/l

0.51

238

1350

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

350

2.68

17.30

3.9

3.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

738

5322

1.43

17.25

3.7

2.7

55.83

61.72

ml/min/173m2

4.07

365

2209

(3000570) Elastase.pancreatic [Mass/mass] in Stool

324

1951

1.69

17.18

1.4

282.14

263.21

ug/g

0.39

201

1186

(3048689) Calprotectin [Mass/mass] in Stool

841

6215

1.39

17.08

2.4

2.1

186.82

154.78

ug/g

1.46

697

4855

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

376

2.60

17.02

1.1

1.2

102.35

92.72

u/l

0.41

315

(3000093) Morphology [Interpretation] in Blood Narrative

151

713

2.14

16.94

1.3

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

204

3.20

16.74

1.3

1.2

0.26

0.23

g/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

176

3.37

16.49

7.1

7.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

175

883

2.00

16.45

1.1

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

112

4.03

16.35

1.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

220

1204

1.85

16.23

4.7

2.6

66.56

63.06

1.59

220

1199

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.88

16.11

1.3

1.2

—

(3035880) pH of Pleural fluid

114

490

2.35

16.06

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

358

2.59

16.04

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

358

2.59

16.04

1.5

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

112

478

2.36

16.03

1.5

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3402

30249

1.22

15.87

3.5

2.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

366

2.56

15.85

1.1

1.2

39.06

24.94

u/l

1.14

303

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

101

416

2.45

15.65

1.3

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

162

810

2.02

15.64

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1833

15295

1.26

15.47

1.8

1.7

29309657.71

29929148.57

pmol/l

0.01

1491

12346

(3006576) Bicarbonate [Moles/volume] in Blood

264

2.82

15.29

7.8

6.4

25.26

24.76

mmol/l

0.38

236

(3017704) Immunofixation for Urine

102

428

2.40

15.19

1.6

1.5

—

(40768804) Tissue Pathology biopsy report

2890

25364

1.22

15.14

2.4

2.2

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

115

3.84

14.97

1.2

18.67

107.88

titre

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

148

3.46

14.91

7.0

7.9

—

(3013727) Leukocytes other/100 leukocytes in Blood

254

2.81

14.61

4.1

3.7

59.85

54.22

1.33

243

(3020682) Albumin/Creatinine [Ratio] in Urine

2578

22437

1.22

14.53

4.4

3.8

16.30

9.72

mg/mmol

5.03

1709

14278

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

5.40

14.45

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

408

2.39

14.39

1.5

10.09

6.99

u/l

1.06

326

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.06

13.95

1.1

1.3

91.86

80.09

0.69

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.06

13.95

1.2

79.00

81.68

0.14

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

908

7009

1.33

13.85

2.8

2.4

10.12

6.95

ug/l

3.49

793

5990

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3281

29333

1.20

13.77

2.2

2.1

91.38

93.30

pmol/l

1.54

1818

15438

(3044927) Protein electrophoresis panel - Urine

159

828

1.94

13.72

1.2

—

(40768443) Skin Pathology biopsy report

436

2983

1.49

13.41

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

101

448

2.27

13.31

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

201

2.95

13.30

1.9

2.1

64.12

38.86

u/l

0.43

188

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

101

450

2.26

13.17

1.4

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

255

1559

1.66

12.84

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

143

738

1.95

12.70

2.6

3.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

316

2.48

12.61

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

317

2.47

12.53

1.1

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

181

1015

1.80

12.44

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

144

754

1.93

12.28

5.2

3.2

—

(3044640) Blood type and Crossmatch panel - Blood

2423

21238

1.20

12.17

3.4

2.5

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

339

2.37

11.76

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

279

2.52

11.74

1.4

1.5

1.50

2.55

1.00

235

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4866

45413

1.18

11.60

4.1

3.8

14.98

15.01

pmol/l

0.24

4422

40416

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

8.59

11.48

1.6

1.4

1.13

1.78

mg/l

0.26

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

102

490

2.10

11.10

1.6

1.4

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

8.54

10.99

1.6

1.4

2.10

1.59

mg/l

0.11

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

8.54

10.99

1.6

1.4

2.87

1.05

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

8.54

10.99

1.6

1.4

2.01

0.58

mg/l

0.66

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

8.54

10.99

1.6

1.4

3.16

1.00

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

8.54

10.99

1.6

1.4

2.33

1.81

mg/l

0.11

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

8.54

10.99

1.6

1.4

1.32

1.42

mg/l

0.05

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

8.54

10.99

1.6

1.4

2.99

2.28

mg/l

0.19

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

8.54

10.99

1.6

1.4

1.23

2.82

mg/l

0.61

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

8.54

10.99

1.6

1.4

3.43

2.67

mg/l

0.14

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

683

8815

0.75

10.99

10.8

8.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

241

2.58

10.97

1.2

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

466

2.12

10.96

1.1

1.45

1.19

u/ml

0.14

250

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

103

500

2.07

10.91

1.6

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

121

623

1.96

10.89

1.2

1.1

1.25

2.03

u/ml

0.55

336

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

103

3.51

10.83

13.5

11.6

5.41

5.27

mmol/l

0.13

103

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

334

2.32

10.77

1.4

65.98

67.54

0.13

272

(3023430) Cat dander IgE Ab [Units/volume] in Serum

362

2.25

10.58

1.0

1.1

1.95

2.73

u/ml

0.35

148

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.34

10.49

1.4

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.34

10.49

1.4

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.34

10.49

1.4

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

136

3.10

10.41

1.3

1.5

5.76

8.93

0.69

(3012565) Volume of 24 hour Urine

322

2.31

10.30

2.1

2.3

1710.09

1854.38

0.69

268

(3014133) Dog dander IgE Ab [Units/volume] in Serum

392

2.18

10.30

1.0

1.1

2.84

2.36

u/ml

0.17

186

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.56

10.17

1.3

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

160

2.89

10.08

1.2

2.08

1.50

mmol/l

0.95

100

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

211

2.62

10.03

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

146

822

1.79

9.99

1.8

1.9

—

(3036048) Francisella tularensis Ab [Titer] in Serum

124

3.16

9.97

1.2

—

580.00

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

174

1032

1.70

9.93

1.5

1.8

21.73

23.04

ug/l

0.12

168

1007

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

229

1458

1.59

9.88

1.6

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

323

2.27

9.79

1.5

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

438

3186

1.40

9.74

2.8

3.2

4.19

4.38

pmol/l

2.82

379

2767

(3003888) Timothy IgE Ab [Units/volume] in Serum

106

543

1.96

9.73

1.1

3.41

3.64

u/ml

0.06

266

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

350

2.21

9.69

1.2

1.1

89.97

86.45

u/l

0.13

316

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

350

2.21

9.69

1.2

1.1

32.78

28.16

u/l

0.29

314

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

119

635

1.89

9.68

1.3

—

(3022145) Colonoscopy Study observation

882

7103

1.27

9.67

1.4

1.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.92

9.56

1.7

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

321

2.25

9.50

1.5

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

217

2.55

9.50

1.1

14.30

1.78

u/ml

1.14

(3011648) Oxygen content in Venous blood

101

516

1.97

9.36

4.7

2.2

10.72

10.89

0.16

101

516

(3023383) Lactate [Moles/volume] in Pleural fluid

280

2.33

9.30

1.3

3.65

3.38

mmol/l

0.24

253

(3037121) Protein [Mass/volume] in Urine

346

2442

1.44

9.14

3.0

0.44

0.31

g/l

2.10

181

1042

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

264

2.36

9.11

2.8

2.5

—

(36660697) Celiac disease serology panel - Serum

544

4141

1.34

9.09

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

132

2.96

9.01

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.59

8.77

1.3

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.66

8.70

2.3

1.5

44.26

42.91

umol/l

0.11

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

360

2.12

8.68

1.8

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

360

2.12

8.68

1.8

1.4

—

(21494434) Karyotype in Bone marrow

118

652

1.82

8.65

1.3

1.2

—

(3016750) Collection duration of Urine

418

2.02

8.43

2.1

2.0

478.81

494.13

min

0.60

291

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

3.67

8.43

1.2

1.0

10.87

16.30

iu/ml

0.35

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

178

2.59

8.31

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

178

2.59

8.31

1.3

1.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1844

16225

1.18

8.26

3.3

2.5

—

(21494755) Public health laboratory ask at order entry panel

185

2854

0.64

8.26

1.3

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

151

2.72

8.16

1.7

1.5

0.36

0.38

ug/l

0.16

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

119

2.95

8.05

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

528

1.87

7.83

1.1

0.47

1.10

u/ml

1.15

235

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

116

2.94

7.79

7.0

7.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

117

668

1.76

7.74

1.6

2.2

—

0.40

—

(3003181) Sodium [Moles/volume] in Urine

198

1294

1.54

7.72

1.5

1.3

65.22

62.63

mmol/l

0.39

179

1033

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

838

6897

1.24

7.58

1.4

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

143

869

1.66

7.55

2.4

2.3

1.18

1.26

g/24h

0.17

421

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

933

7779

1.23

7.46

3.2

4.0

19.69

26.59

ug/l

0.34

776

6452

(42529406) Shigella sp [Presence] in Stool by Culture

251

1736

1.46

7.46

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

250

1728

1.46

7.45

1.3

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

226

2.31

7.37

1.3

1.4

25.94

22.96

0.26

187

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.34

7.36

1.3

9.13

409237.96

nmol/l

0.72

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

317

2.09

7.33

1.0

1.1

0.21

0.22

u/ml

0.05

118

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.83

7.24

1.2

1.6

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

122

2.79

7.14

1.2

0.49

1.61

mmol/l

1.19

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.18

7.10

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

7.91

7.09

1.6

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

199

1329

1.51

7.05

1.1

15.03

7.31

u/ml

0.58

107

(3007919) Fasciola sp Ab [Titer] in Serum

13.77

6.88

1.3

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

690

8412

0.80

6.88

4.8

32.32

33.08

1.09

517

5555

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

3.56

6.85

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.97

6.79

1.3

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

244

1713

1.44

6.74

1.3

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

115

2.79

6.72

2.6

3.1

5.34

7.13

mg/l

0.87

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

288

2.09

6.71

1.1

8.74

11.24

iu/ml

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.21

6.68

4.2

4.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

138

860

1.62

6.65

1.7

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

498

3915

1.29

6.64

2.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

137

853

1.62

6.63

1.7

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

310

2280

1.37

6.55

1.1

379.29

193.58

titre

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

181

1205

1.51

6.54

1.2

1.3

52.65

38.49

u/l

0.40

156

1036

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

139

872

1.60

6.53

1.7

1.4

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

395

1.91

6.49

1.0

293.61

285.56

mg/l

0.45

352

(3025468) Yersinia sp identified in Specimen by Organism specific culture

136

850

1.61

6.49

1.7

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

259

2.13

6.48

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

136

851

1.61

6.46

1.7

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

390

1.91

6.40

2.1

1.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

228

2.20

6.38

4.7

2.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

228

2.20

6.38

4.7

2.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

136

854

1.60

6.37

1.7

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

230

3227

0.70

6.37

2.0

1.8

—

(3020491) Glucose [Moles/volume] in Blood

470

1.82

6.34

2.2

2.1

7.61

7.05

mmol/l

1.04

317

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

291

2131

1.38

6.33

1.1

0.88

1.19

u/ml

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

109

648

1.69

6.33

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

8.14

6.32

1.3

—

(44813793) Dust mix specific IgE antibody measurement

303

2.02

6.26

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

114

2.73

6.26

1.2

1.3

20.99

21.71

0.03

(3047189) Immunofixation for 24 hour Urine

385

1.88

5.99

1.8

1.5

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

7.23

5.91

1.1

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

223

2.16

5.88

4.6

1.7

200.97

122.69

umol/l

0.51

128

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

101

2.78

5.87

1.4

74.63

72.59

0.12

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1809

16262

1.15

5.82

1.8

1.6

1.43

1.33

mmol/l

5.58

1481

13431

(3024263) Appearance of Synovial fluid

382

1.87

5.81

1.7

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

6.85

5.72

1.1

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.87

5.72

1.1

1.2

3482.33

2945.28

ng/l

0.12

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

389

1.83

5.51

1.9

1.7

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

270

2.01

5.49

1.2

1.3

78.02

423.03

ug/l

1.28

141

(3044416) Complement C4 [Mass/volume] in Pleural fluid

3.62

5.47

1.1

0.10

0.07

g/l

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

4.60

5.47

1.9

2.0

1.28

1.53

mg/l

0.44

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

285

1.97

5.42

1.4

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

134

881

1.53

5.22

1.5

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.47

5.16

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2128

23192

0.89

5.16

4.2

4.7

21.91

22.19

0.35

987

12263

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.58

5.16

1.7

1.1

—

(3045424) Erythrocytes [Presence] in Urine

160

1097

1.47

5.10

1.8

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

334

1.86

5.10

1.5

1.3

1.41

1.18

nmol/l

0.68

246

(3013512) EKG study

2254

20704

1.12

5.06

5.2

4.4

—

(3020393) Adenovirus Ag [Presence] in Stool

3.08

5.05

1.2

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

535

1.67

5.05

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.90

5.02

1.0

1.6

—

(3004775) Volume in Urine collected for unspecified duration

608

1.62

4.92

2.3

2.2

575.46

649.22

1.11

376

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.42

4.90

1.4

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

536

1.65

4.77

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

300

2313

1.31

4.73

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

593

1.61

4.68

2.0

4616.64

3124.49

u/l

0.22

241

(3010144) Erythrocytes [#/volume] in Synovial fluid

106

681

1.56

4.63

1.7

1.3

87712.41

148472.76

e6/l

0.57

464

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

134

2.32

4.58

1.2

186.44

34.96

mg/l

0.37

103

(3020191) Ethanol [Moles/volume] in Serum or Plasma

428

1.71

4.57

1.4

1.3

1.17

1.22

promille

0.10

331

(3035320) C reactive protein [Mass/volume] in Body fluid

457

1.67

4.36

2.8

2.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

147

2077

0.70

4.36

1.7

1.5

—

(40765096) Chromosome analysis panel by Banding

217

1.99

4.34

1.2

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

190

2.06

4.33

1.1

1619.82

1620.92

miu/ml

0.00

190

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

5.01

4.31

6.8

11.3

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.49

4.24

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

114

2.37

4.22

1.3

1.2

312.60

344.59

u/l

0.03

(40757494) Bilirubin.total [Moles/volume] in Blood

401

1.70

4.21

2.4

2.5

24.13

43.60

umol/l

—

(3036525) Urea [Moles/time] in 24 hour Urine

3.85

4.18

3.3

3.1

—

(40758292) HTLV I+II Ab panel - Serum

2.66

4.14

1.3

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

567

1.58

4.08

1.3

1.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.86

4.05

3.7

2.7

0.78

1.14

mg/l

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

251

1.88

4.05

1.5

1.4

23.94

19.10

0.53

228

(3016038) Potassium [Moles/volume] in Urine

476

1.62

4.00

1.3

1.1

33.00

34.69

mmol/l

0.32

392

(40768441) Liver Pathology biopsy report

430

1.66

4.00

1.5

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.79

3.86

1.3

1.6

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

2.91

3.73

1.2

—

mmol/l

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6587

64497

1.12

3.72

36.5

19.9

139.06

139.63

mmol/l

54.73

6504

62770

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5751

55917

1.10

3.69

5.1

4.7

2.08

2.14

mu/l

0.45

5260

50048

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

6.67

3.67

3.4

4.8

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.47

3.62

1.1

1.2

16.67

19.23

u/l

0.43

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.50

3.60

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1705

15687

1.11

3.55

1.5

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

236

1.83

3.45

1.3

1.1

32.65

40.59

g/l

3.04

117

(40761511) CBC panel - Blood by Automated count

6410

62731

1.11

3.44

27.9

16.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5907

57578

1.10

3.42

7.2

6.4

41.72

40.76

mmol/mol

8.43

5463

52347

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.08

3.39

2.5

5.7

—

(3008295) Osmolality of Serum or Plasma

102

704

1.45

3.29

1.3

271.28

278.54

mosm/kgh2o

2.48

527

(3023103) Potassium [Moles/volume] in Serum or Plasma

6589

64623

1.11

3.25

36.9

20.0

4.02

4.00

mmol/l

5.66

6500

62792

(3028707) Methadone [Presence] in Urine by Screen method

356

1.63

3.18

2.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

118

1626

0.72

3.12

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.25

3.12

1.0

1.1

0.94

44.26

u/ml

0.49

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.38

3.05

1.5

1.2

102.38

110.39

ug/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.58

3.04

1.5

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

4.29

2.99

1.3

1.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

603

1.46

2.98

1.5

1.6

14.43

26.26

u/ml

2.89

138

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.75

2.98

1.3

1.4

0.82

0.94

ml/s/173m2

—

(3001729) Color of Synovial fluid

2.47

2.95

2.4

1.5

—

(3048879) Bone marrow aspiration report

227

1.77

2.93

2.1

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

259

1.70

2.85

1.6

1.5

9.65

8.79

ug/l

0.14

228

(3019150) Specific gravity of Urine by Refractometry

1506

13916

1.10

2.85

5.3

4.4

1.02

kg/l

0.04

266

2180

(3035637) Corticotropin [Mass/volume] in Plasma

107

768

1.40

2.84

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

360

3021

1.20

2.83

1.2

115.87

136.18

iu/ml

0.50

111

1063

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1526

16460

0.91

2.80

3.0

3.2

0.74

0.82

ug/l

2.47

1095

11754

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

398

3377

1.19

2.78

1.3

43.09

61.11

au/ml

0.92

187

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

316

2629

1.21

2.73

2.9

3.3

8502.53

1606.44

u/ml

0.39

263

2247

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

167

1.86

2.70

1.3

0.35

0.31

g/l

1.43

135

(3016135) IgD [Mass/volume] in Serum

6.00

2.69

1.3

1.2

425.83

92.85

mg/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.33

2.64

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

147

1.91

2.64

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

250

1.68

2.64

1.6

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

273

1.65

2.64

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.21

2.63

1.2

1.8

45.67

40.23

pmol/l

0.14

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.39

2.62

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1091

0.69

2.62

1.6

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

513

1.47

2.61

1.3

128.57

293.02

titre

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

155

1.87

2.60

1.2

1.3

112.38

110.76

0.10

136

(3002331) Protein [Mass/volume] in Peritoneal fluid

156

1.86

2.56

1.4

220.14

27.52

g/l

0.47

121

(3044009) aPTT.lupus sensitive (LA screen)

2.86

2.54

1.4

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

2.42

2.53

2.9

1.7

66.80

65.72

—

(3008898) HLA-B27 [Presence]

171

1344

1.28

2.50

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

433

3740

1.17

2.47

2.4

27.52

22.91

au/ml

0.20

215

(3032057) Clostridioides difficile [Presence] in Stool

180

1.78

2.46

2.3

1.8

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.17

2.40

1.1

9.82

7.72

u/ml

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

376

1.52

2.39

1.7

1.8

1.62

2.67

u/field

0.70

256

(3023511) Choriogonadotropin [Units/volume] in Urine

258

1.63

2.38

1.5

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

4.12

2.36

1.0

—

(3020650) Glucose [Presence] in Urine

132

1.90

2.35

1.8

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

145

1129

1.29

2.31

1.2

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

119

1.94

2.29

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.75

2.27

1.0

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

5.56

2.21

1.2

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

217

1.66

2.21

1.0

1.2

—

(3014891) Appearance of Pleural fluid

128

1.88

2.20

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.24

2.17

1.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

610

1.38

2.17

2.0

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

173

1.74

2.16

1.1

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

148

1168

1.27

2.15

1.4

32.73

31.59

iu/l

0.14

117

990

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

586

1.39

2.14

1.3

1.60

1.45

nmol/l

0.49

516

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.62

2.14

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.78

2.13

1.5

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

274

1.57

2.13

5.7

5.0

40.71

55.19

u/ml

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

290

1.55

2.13

1.0

1.1

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

2.37

2.11

2.4

1.6

5.29

13.71

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

511

0.61

2.11

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

497

0.60

2.09

1.0

271.74

323.84

ng/l

0.55

326

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.70

2.06

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

161

1.74

2.05

1.8

1.3

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

4.00

2.04

1.0

1.00

1.27

u/field

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.00

2.04

1.3

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

125

1.84

2.02

2.1

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

3.08

2.01

6.3

9.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

748

1.33

2.01

1.5

1.3

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.22

2.00

1.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

107

820

1.31

1.97

1.4

1.3

8.70

1.93

nmol/l

0.39

785

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

501

0.62

1.97

1.0

32.25

44.03

ng/l

0.86

323

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

499

0.62

1.94

1.0

844.42

689.45

ng/l

1.15

321

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6566

64738

1.08

1.92

20.2

11.0

25.45

25.60

u/l

0.24

6465

61922

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.31

1.87

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

182

1.65

1.84

1.7

1.4

22.71

16.21

pmol/l

0.64

143

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

269

1.53

1.83

1.4

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

442

1.41

1.83

1.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

4.17

1.82

2.6

2.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

102

787

1.30

1.81

1.2

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

108

840

1.29

1.81

1.1

56.23

261.67

iu/ml

0.54

171

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6012

61080

0.94

1.81

5.5

5.3

2.49

2.60

mmol/l

17.31

5416

55206

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5863

57613

1.07

1.80

29.3

15.9

72.91

74.51

ml/min/173m2

6.29

5273

47834

(4212803) Bone marrow aspirate examination

2.06

1.80

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

236

1999

1.19

1.79

1.6

—

(40768800) Prostate Pathology biopsy report

155

1896

0.81

1.79

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

958

0.74

1.79

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

161

1.68

1.77

1.3

1.2

280.00

282.58

pmol/l

0.01

118

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

582

1.34

1.76

1.0

1.1

13.20

3.47

u/ml

0.73

211

(3016018) Differential panel - Cerebral spinal fluid

583

1.34

1.74

1.2

1.3

—

(3045462) Protein/Creatinine [Ratio] in Urine

2.50

1.73

3.0

4.5

54.39

48.37

g/mol

—

(3027008) Opiates [Presence] in Urine

101

785

1.29

1.72

1.9

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

364

1.43

1.71

1.5

1.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

148

1.69

1.8

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.00

1.69

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

275

1.49

1.68

1.1

1.3

60.67

60.23

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

104

1.83

1.66

1.3

1.2

—

(3028300) Cannabinoids [Presence] in Urine

101

789

1.28

1.66

1.9

1.8

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.16

1.66

8.5

5.7

411.83

365.26

umol/l

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

180

1.61

1.66

1.4

1.6

14.83

13.89

g/l

0.24

140

(3044007) Cell count panel - Peritoneal fluid

188

1.60

1.65

2.3

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

346

3925

0.88

1.65

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

105

826

1.27

1.64

1.4

1.3

0.14

0.29

nmol/l

1.97

(3034274) Bile acid [Moles/volume] in Serum --fasting

293

1.47

1.64

1.1

1.6

5.67

10.33

umol/l

1.37

203

(3036180) Methadone [Presence] in Urine

120

1.75

1.61

1.5

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2801

29011

0.95

1.57

4.8

5.4

3.26

3.93

ug/l

0.54

2434

25707

(3009214) Lutropin [Units/volume] in Serum or Plasma

133

1085

1.23

1.54

1.4

11.51

10.61

u/l

0.27

108

870

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

146

1204

1.22

1.53

3.1

1.6

1.12

0.81

nmol/l

3.94

118

990

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.33

1.52

11.0

8.2

—

(3016879) Cocaine [Presence] in Urine

729

1.28

1.52

1.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

241

1.50

1.51

1.0

—

(3027944) Amphetamines [Presence] in Urine

774

1.27

1.51

1.8

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

154

1.63

1.49

1.2

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

333

1.41

1.49

1.1

267.78

294.19

mg/l

0.58

286

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

275

1.46

1.48

3.3

2.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.00

1.48

1.5

1.1

1.85

1.75

umol/24h

0.12

(3033799) Differential panel - Peritoneal fluid

218

1.52

1.48

2.2

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

631

5786

1.10

1.47

1.6

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.37

1.45

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

171

1.58

1.45

2.0

2.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

752

1.27

1.45

1.2

1.3

299.33

288.98

pmol/l

0.11

629

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5807

58931

0.95

1.44

4.9

4.7

1.40

1.43

mmol/l

6.37

5198

53124

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

106

852

1.25

1.43

3.0

3.6

24.53

33.46

u/ml

1.02

100

827

(3045414) Leukocytes [Presence] in Urine

329

2917

1.13

1.42

2.3

2.0

—

(3049717) Cytology report of Urine Cyto stain

377

3371

1.12

1.42

2.8

—

(3000764) Benzodiazepines [Presence] in Urine

781

1.26

1.42

1.9

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5864

59485

0.95

1.41

5.0

4.7

4.37

4.47

mmol/l

11.30

5284

54032

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

116

943

1.23

1.41

2.9

2.0

23.34

26.11

mg/l

0.25

225

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

632

1.28

1.39

1.8

2.1

1.44

1.74

u/field

0.28

227

(3019174) dRVVT (LA screen)

2.18

1.39

1.4

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.61

1.36

1.3

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

175

1.54

1.34

1.0

1.1

0.76

1.58

u/ml

0.66

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.13

1.33

1.2

—

(3002256) Pathology report gross observation

931

8724

1.08

1.32

1.4

1.3

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

350

1.37

1.32

1.2

1.1

48.31

43.58

mg/l

0.28

289

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

176

1.54

1.31

1.0

1.2

22.67

33.50

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

106

1.70

1.29

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

193

1.50

1.29

2.5

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.89

1.28

1.2

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

175

0.51

1.28

1.4

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

122

1.64

1.27

2.0

3.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.72

1.26

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

341

0.64

1.26

1.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

179

1536

1.17

1.26

3.0

3.2

342.96

751.72

u/ml

0.83

166

1402

(3008037) Lactate [Moles/volume] in Venous blood

209

1817

1.15

1.24

4.8

3.4

1.61

1.67

mmol/l

0.52

202

1774

(3020911) Cortisol [Moles/time] in 24 hour Urine

171

1.52

1.22

1.5

1.4

102.69

238.01

nmol/24h

0.98

171

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.63

1.21

1.2

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

246

1.42

1.20

2.2

42.26

56.14

umol/l

1.16

205

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

396

0.68

1.20

1.9

1.7

—

(3011985) Renin [Units/volume] in Plasma

809

1.23

1.19

1.3

1.4

45.60

53.88

mu/l

0.32

709

(3038515) Glucose [Moles/volume] in Venous blood

198

1721

1.15

1.19

5.0

3.5

7.52

7.71

mmol/l

0.49

191

1683

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

287

0.63

1.18

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

287

0.63

1.18

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

359

0.67

1.18

1.0

1.1

4.26

11.83

nmol/l

—

(4034850) Laboratory test

233

2051

1.14

1.18

14.8

11.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

286

0.63

1.17

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

286

0.63

1.17

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

102

1.67

1.16

1.9

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

731

1.23

1.16

1.4

1.3

—

nmol/l

—

(40768793) Breast Pathology biopsy report

132

1114

1.19

1.15

1.4

1.3

—

(1761868) Lipid panel - Serum or Plasma

1726

17969

0.95

1.15

3.4

3.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.73

1.14

1.5

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

134

1.57

1.14

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.14

0.0

1.1

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.33

1.12

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.00

1.12

1.4

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

119

1.60

1.11

1.2

1.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

257

0.62

1.10

1.4

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.26

1.10

8.7

9.9

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

320

1.35

1.08

1.1

1.2

233.83

305.13

u/l

0.60

291

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

164

1421

1.16

1.06

1.3

717.56

570.13

mg/l

0.40

150

1336

(3017446) Testosterone [Moles/volume] in Serum or Plasma

522

4832

1.09

1.05

2.6

2.1

12.10

12.03

nmol/l

0.07

448

4202

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

146

1255

1.17

1.05

1.7

3.96

4.55

iu/l

0.32

397

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

314

1.34

1.04

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

306

1.34

1.03

1.1

—

(3022621) pH of Urine by Test strip

482

4453

1.09

1.03

4.0

3.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

145

1250

1.16

1.01

1.2

3.87

3.86

mmol/l

0.03

133

1164

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

177

0.56

1.01

1.1

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

226

0.62

1.00

1.6

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

1.00

3.1

2.5

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.00

1.00

4.7

3.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

308

1.33

0.99

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

309

0.68

0.99

1.5

—

(3026726) Creatinine [Moles/volume] in Specimen

1.80

0.98

3.3

2.6

431.00

555.89

umol/l

0.12

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.89

0.94

1.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.22

0.93

1.0

1.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.73

0.92

1.1

4.6

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.82

0.92

1.1

1.7

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

126

1.51

0.91

1.5

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

187

2104

0.89

0.90

5.6

4.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.07

0.89

1.0

1.3

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.07

0.89

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.91

0.88

1.0

1.1

—

(3025577) Chromium [Mass/volume] in Blood

502

1.24

0.88

1.8

2.0

1.46

2.21

ug/l

3.10

416

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.86

0.87

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

512

1.23

0.86

6.6

2.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

128

1.49

0.85

1.3

1.1

0.76

0.67

umol/24h

0.28

(3033705) Calcium.ionized [Moles/volume] in Venous blood

123

1068

1.15

0.83

3.5

2.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

206

1851

1.12

0.82

2.4

2.2

153.43

107.09

ug/min

0.66

127

1065

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

100

855

1.17

0.82

1.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

535

1.22

0.81

1.1

—

44.99

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

273

2494

1.10

0.80

1.6

1.7

—

(3000330) Specific gravity of Urine by Test strip

347

3751

0.92

0.79

4.6

3.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

402

1.25

0.78

2.3

2.1

86.22

182.25

ug/min

—

107

(3014599) Egg white IgE Ab [Units/volume] in Serum

165

1.40

0.77

1.0

1.1

0.65

2.33

u/ml

1.26

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

217

1.34

0.76

25.6

18.2

1434.14

1405.48

nmol/l

0.09

209

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.57

0.74

2.2

2.7

0.54

0.46

u/field

0.11

(3043238) Trisomy 21 risk [Likelihood] in Fetus

243

0.70

0.73

1.4

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

254

1.30

0.73

1.0

1.1

1.06

1.13

u/l

0.84

129

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

139

1234

1.13

0.71

1.2

1.4

462.93

946.20

e6/l

0.60

107

1000

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

291

1.27

0.70

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

408

1.23

0.70

1.7

1.4

0.16

0.24

nmol/l

2.63

304

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

213

1.32

0.68

2.0

6959.10

17247.06

e6/l

—

124

(3015076) Soybean IgE Ab [Units/volume] in Serum

136

1.40

0.66

1.1

1.09

0.49

u/ml

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

162

1.36

0.66

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

138

1233

1.12

0.65

1.2

1.4

76.39

23.66

e6/l

0.51

946

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

154

1.36

0.64

1.0

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

118

1047

1.13

0.63

1.4

1.7

324.36

312.91

mu/l

0.14

105

963

(3003338) MCHC [Mass/volume]

4874

49283

0.97

0.63

41.0

21.9

329.29

331.81

g/l

65.66

4833

48788

(3047352) Trisomy 18 risk [Likelihood] in Fetus

235

0.72

0.63

1.4

—

(3005033) Fetal Nuchal fold Thickness US

234

0.73

0.62

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1090

0.88

0.60

1.9

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

722

1.15

0.60

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

209

1.29

0.60

18.4

13.0

842.48

825.39

nmol/l

0.07

196

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5654

57012

0.97

0.58

4.5

4.2

1.35

1.28

mmol/l

11.80

5029

50877

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.46

0.57

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

484

1.18

0.56

3.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

167

1.32

0.56

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

238

1.26

0.56

2.3

2.2

457.26

3977.38

e6/l

0.57

170

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

466

1.18

0.56

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

168

1.31

0.54

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.43

0.52

2.2

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.43

0.52

2.2

2.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.50

0.51

1.0

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

161

1.31

0.51

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.41

0.51

12.0

10.4

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

1.41

0.50

1.2

1.5

75.85

73.18

0.38

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

1.41

0.50

1.2

1.5

505.15

405.71

mu/l

0.25

(3027035) Albumin [Mass/time] in 24 hour Urine

1.49

0.49

1.2

—

609.28

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.56

0.48

2.3

2.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

128

1164

1.10

0.48

1.4

1.3

—

(3025130) Human papilloma virus identified in Specimen

409

1.17

0.48

1.8

1.7

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

110

0.64

0.48

1.0

—

(3015183) Erythrocyte sedimentation rate

190

1.26

0.47

1.2

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

328

1.19

0.46

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

243

0.78

0.45

1.1

710.86

327.25

ng/l

—

(3023410) Appearance of Cerebral spinal fluid

524

1.15

0.45

1.3

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

256

1.21

0.44

1.7

1.6

2.60

6.36

nmol/l

1.17

218

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

247

1.22

0.44

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

862

0.89

0.43

1.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

239

2250

1.06

0.41

1.6

1.7

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

12624.80

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.33

0.40

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

324

1.17

0.40

5.4

3.7

—

(3000034) Microalbumin [Mass/volume] in Urine

663

1.12

0.39

2.8

3.1

83.06

47.89

mg/l

0.45

498

(3019225) pH of Specimen

750

7270

1.03

0.39

6.3

4.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.32

0.37

2.0

1.8

—

(3051101) Glucose [Moles/volume] in Cord blood

147

0.75

0.37

6.7

6.3

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.35

0.37

4.6

3.9

—

0.00

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

268

0.82

0.37

1.1

1.4

1.62

1.54

g/l

0.47

268

(1002224) Polysomnography panel

185

1739

1.07

0.35

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.36

0.34

1.2

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.33

0.33

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

155

0.77

0.33

1.4

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

182

1.21

0.33

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

388

1.13

0.32

2.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

304

1.15

0.31

1.3

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

114

1060

1.08

0.31

1.9

195.29

199.08

pmol/l

0.16

102

981

(4094501) Cardiovascular stress test using bicycle ergometer

158

1676

0.94

0.30

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

138

1.23

0.30

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.33

0.30

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.31

0.30

2.0

2.7

30.32

74.32

pmol/l

4.34

(3006442) Creatine [Moles/volume] in Serum or Plasma

420

1.12

0.29

2.1

1.7

91.83

91.70

umol/l

0.01

420

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.27

0.27

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

149

1.21

0.27

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.21

0.26

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

289

0.86

0.26

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5964

59881

0.98

0.26

5.3

5.0

6.10

6.08

mmol/l

0.48

5364

53455

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

425

0.89

0.25

1.2

1.4

34.68

30.82

u/l

0.30

348

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

133

1.20

0.24

2.3

1.6

161.06

137.72

ng/l

0.33

133

(40761535) Cells panel - Urine sediment

616

6019

1.03

0.23

4.7

3.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.28

0.23

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.27

0.22

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.22

0.22

2.0

1.8

—

(3000285) Sodium [Moles/volume] in Blood

116

1.21

0.22

1.2

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1316.00

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3008607) Semen analysis panel

0.00

0.21

0.0

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

148

1544

0.96

0.19

6.1

3.8

26.92

30.08

mg/l

0.58

109

1000

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

164

0.85

0.18

2.0

2.3

7.63

8.06

mmol/l

—

102

(3000963) Hemoglobin [Mass/volume] in Blood

6670

66849

0.99

0.17

46.2

24.7

130.58

133.83

g/l

52.22

6609

65605

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

445

1.08

0.17

2.4

3.6

77.57

172.98

nmol/l

4.11

440

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

278

0.90

0.17

1.4

1.3

5.94

6.14

mmol/l

0.36

261

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.74

0.17

7.4

4.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.13

0.16

1.1

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

360

0.92

0.16

1.5

1.4

135.88

189.40

pmol/l

1.07

360

(3051593) INR in Capillary blood by Coagulation assay

432

0.93

0.16

11.1

11.9

—

(3026361) Erythrocytes [#/volume] in Blood

6670

66835

0.99

0.16

45.8

24.5

4.33

4.43

e12/l

35.65

6541

64528

(3024731) MCV [Entitic volume]

6670

66831

0.99

0.15

45.7

24.4

92.38

91.58

33.47

6609

65587

(3035941) MCH [Entitic mass]

6670

66830

0.99

0.15

45.6

24.4

30.45

30.44

0.29

6610

65584

(3002619) Bacteria identified in Specimen by Culture

121

1.16

0.15

1.3

1.2

—

(3007461) Platelets [#/volume] in Blood

6669

66817

0.99

0.14

45.9

24.5

245.32

240.78

e9/l

5.95

6561

64763

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

243

2367

1.03

0.14

3.3

3.8

54.39

69.08

u/ml

0.52

233

2268

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

450

1.07

0.14

3.4

5.1

105.08

53.74

u/ml

0.43

134

(3010813) Leukocytes [#/volume] in Blood

6672

66841

0.99

0.14

45.8

24.5

7.80

6.88

e9/l

76.20

6543

64529

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

300

2936

1.02

0.13

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

155

1505

1.03

0.12

2.0

1.7

21.95

3.67

mg/l

6.40

137

1123

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

254

2485

1.02

0.12

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

621

1.05

0.11

1.3

1.2

7.24

7.83

mmol/l

1.07

523

(1617658) Protocol used for examination of sentinel lymph nodes

394

0.94

0.11

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

6670

66788

0.99

0.10

46.7

24.6

39.22

39.71

4.57

6136

61607

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.11

0.09

1.4

1.1

—

(40762814) Titanium [Mass/volume] in Blood

135

0.89

0.09

2.3

2.1

4.15

3.75

ug/l

—

(4146454) Self-monitoring of blood glucose

839

0.97

0.09

2.6

2.7

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.03

0.08

1.7

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

153

1498

1.02

0.08

1.6

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

0.83

0.07

1.2

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

175

1782

0.98

0.07

3.6

2.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.02

0.07

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.02

0.07

3.2

2.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

246

1.06

0.06

1.3

1.2

138.58

163.89

mmol/24h

1.02

246

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

227

1.06

0.06

2.1

2.9

31.16

29.12

umol/l

0.30

168

(3009466) Valproate [Moles/volume] in Serum or Plasma

868

0.98

0.05

5.8

4.5

350.51

348.03

umol/l

0.05

734

(3024869) Neuronal Ab [Presence] in Serum

140

0.93

0.04

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

635

1.02

0.04

1.1

1.2

317.47

336.04

nmol/l

0.31

495

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

170

0.94

0.04

1.9

2.3

1.67

1.27

ug/l

0.31

160

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

220

1.05

0.03

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

158

0.95

0.02

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

331

1.03

0.02

3.8

6.3

—

(4281824) Cell count and differential, peritoneal fluid

613

1.01

0.01

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

106

0.94

0.01

1.3

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

216

0.97

0.00

1.0

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

122

0.98

0.00

2.4

1.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

124

0.97

0.00

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

175

0.97

0.00

1.0

1.3

86.19

138.85

nmol/l

1.74

132

(3022689) Creatine [Moles/volume] in Urine

188

1.01

0.00

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

584

5840

1.00

0.00

1.4

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.80

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.1

—

1.24

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.01

-0.00

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.91

-0.00

1.0

—

(3049233) Organic acids panel - Urine

0.00

-0.00

0.0

1.2

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.8

—

14.00

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.95

-0.00

1.0

1.1

7.83

10.86

u/l

—

(3028717) Thiamine [Mass/volume] in Blood

0.90

-0.00

1.0

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.8

—

0.27

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

25.80

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

17.00

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

39.83

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.00

-0.00

1.2

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

-0.00

0.0

1.2

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: J10_INTERSTITIUM – Other respiratory diseases principally affecting the interstitium

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other respiratory diseases principally affecting the interstitium

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Other respiratory diseases principally affecting the interstitium (J10_INTERSTITIUM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints